Flumioxazin by Massachusetts. Department of Environmental Protection. Office of Research and Standards. & Massachusetts. Division of Crop and Pest Services. Pesticide Program.
  
   
 
 
Flumioxazin 
 
 
 
 
2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Massachusetts Department of Agricultural Resources 
Pesticide Program  
 
and 
 
Massachusetts Department of Environmental Protection 
Office of Research and Standards 
Boston, MA  
  
ii 
 MDAR/MassDEP 
Table of Contents 
1 Chemical Overview ................................................................................................................ 1 
1.1.  Chemical Identity ......................................................................................................... 1 
1.2.  Registration History ...................................................................................................... 1 
1.3. Registered Products in Massachusetts.............................................................................. 1 
1.4 Aquatic Use of Flumioxazin ............................................................................................ 2 
1.5 Pesticide Type, Class, and Mode of Action ..................................................................... 2 
1.6  Physical and Chemical and Environmental Fate Properties............................................ 2 
1.6.1 Hydrolysis ................................................................................................................. 2 
1.6.2 Photolysis .................................................................................................................. 3 
1.6.3 Biotic Degradation .................................................................................................... 3 
1.6.4  Mobility of Flumioxazin ............................................................................................... 4 
1.6.5 Mobility of 482-HA, APF and THPA....................................................................... 4 
1.6.6 Bioconcentration ....................................................................................................... 5 
1.6.7 Metabolism Pathways ............................................................................................... 5 
1.6.8   Degradate Profile ......................................................................................................... 6 
1.6.9  Field Dissipation Studies .............................................................................................. 9 
2 Human Health Risk Assessment ........................................................................................... 12 
2.1. Hazard Characterization and Toxicity Endpoint Selection ............................................ 12 
2.2 Risk Associated with Recreational Uses of Water Bodies ............................................. 14 
2.3 Drinking Water Assessment ........................................................................................... 14 
2.4.  Deficiencies and Data Gaps .......................................................................................... 16 
3.0  Ecological Risk Assessment .............................................................................................. 17 
3.1 Ecological Hazard Characterization ............................................................................... 17 
3.1.1 Toxicity to Aquatic Animals ........................................................................................ 17 
3.1.2  Toxicity to Terrestrial Species .................................................................................... 19 
3.1.3  Toxicity to  to Plants ................................................................................................... 20 
3.1.4  Degradate Toxicity...................................................................................................... 20 
3.2  Exposure Assessment for Direct Applications to Water ................................................ 21 
3.2.1  Aquatic Exposure Assessment ................................................................................ 21 
3.2.2 Terrestrial Exposure Assessment ............................................................................ 23 
3.3 Risk Characterization and Risk Description .................................................................. 24 
3.3.1  Aquatic Animals ......................................................................................................... 24 
3.3.2  Terrestrial Organisms.................................................................................................. 26 
3.3.3  Risk to Non-Target Plants ........................................................................................... 27 
  
iii 
 MDAR/MassDEP 
3.3.4  Threatened and Endangered Species Concerns .......................................................... 28 
3.3.5  Uncertainties and Data Gaps ....................................................................................... 29 
4.0   References ............................................................................................................................. 31 
Appendix 1 ................................................................................................................................... 1-1 
Aquatic Toxicity Estimation of Flumioxazin, and its degradates 482-HA, APF, and THPA                                                                                                            
using ECOSAR Aquatic Toxicity Prediction Program ................................................................ 1-1 
Appendix 2 ................................................................................................................................... 2-1 
Estimated Environmental Concentrations (EECs) and Dissipation Behavior of Flumioxazin 
Following Direct Application to Water Using the AQUATOX Model ....................................... 2-1 
Appendix 3 ................................................................................................................................... 3-1 
Information Related to Exposure and Risk Assessment of Flumioxazin .................................... 3-1 
Appendix 4 ................................................................................................................................... 4-1 
Refined Aquatic Risk Assessment for Flumioxazin and Degradates .......................................... 4-1 
 
 
 
  
MDAR/MassDEP 1 June 2013 
 
1 Chemical Overview  
 
1.1.  Chemical Identity 
Flumioxazin is part of the N-phenylphthalimide class.  
 
Flumioxazin is the common name for N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-
benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide. The chemical structure is shown in Figure 2.1. 
 
 
 
Figure 1.1 Flumioxazin Chemical Structure 
 
 
 
1.2.  Registration History 
Flumioxazin is a broad-spectrum contact herbicide. It was first registered by EPA in 2001 for use 
on soy beans and peanuts (USEPA, 2001). As of 2011, it was registered for pre- and post-
emergent weed control in a variety of fruit, vegetable and other agricultural crops, ornamentals, 
forestry, aquatic settings, and non-crop areas. Tolerances for flumioxazin have been established. 
In 2010, EPA approved the use of flumioxazin for the control of vegetation in aquatic sites. 
Registration review of flumioxazin was initiated in 2011 (USEPA, 2011A).  
 
 
1.3. Registered Products in Massachusetts 
The current list of aquatic herbicides containing flumioxazin that are registered in Massachusetts 
can be accessed at http://www.mass.gov/eea/agencies/agr/pesticides/aquatic-vegetation-
management.html on the Massachusetts Department of Agricultural Resources (MDAR) Aquatic 
Vegetation Management website. MDAR updates this list regularly with changes.  In addition, 
the MDAR can be contacted directly at (617) 626-1771 for more specific questions regarding 
these products. 
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1.4 Aquatic Use of Flumioxazin 
Flumioxazin provides control of various submerged, emergent, and floating aquatic plants and 
filamentous green algae. Flumioxazin-based aquatic herbicides may be broadcast applied to the 
water surface or injected below the water surface.  
 
1.5 Pesticide Type, Class, and Mode of Action  
Flumioxazin is a member of the chemical family of N-phenylphthalimides (USEPA, 2001). They 
are light dependent peroxidizing herbicides (LDPH) which control plant growth by blocking 
heme and chlorophyll biosynthesis resulting in the accumulation of phototoxic porphyrins in 
plant and animal tissues (USEPA, 2010). They inhibit the enzyme protoporphyrinogen oxidase 
(PPO or protox) which is the last enzyme in the heme and chlorophyll biosynthetic pathway. 
Protox inhibition in plants results in a rapid accumulation of protoporphyrin IX. In the presence 
of ultraviolet light, protoporphyrin IX can become a powerful source of singlet oxygen which in 
plants causes lipid membrane peroxidation leading to a rapid loss of turgidity and foliar burns. 
Protox exists in both plants and animals and the enzyme from both sources has been shown to be 
highly sensitive to many LDPHs (USEPA, 2011B).  
 
Studies with peroxidizing herbicides in rodents indicated that these substances act as protox 
inhibitors and interfere with the conversion of protoporphyrinogen to protoporphyrin. However, 
the inhibition is reversible and porphyrin levels returns to normal following cessation of 
exposure. Excess protoporphyrinogen is excreted in the bile and does not significantly 
accumulate in plasma at lower levels of exposure. Significant changes in plasma porphyrin 
spectrum were only observed in mice fed with a diet with high levels (> 10 mg/kg) of oxadiazon, 
a peroxidizing herbicide. Skin fluorescence was observed at dietary levels of oxidiazon higher 
than 50 mg/kg. In humans with a hereditary protox disorder (variegate porphyria) protox activity 
is reduced in all tissues. Symptoms may include porphyrin-related photosensitivity or acute 
porphyric crisis with neurological symptoms, but in most patients the metabolic defect never 
becomes clinically manifest. Krijt (1999) observed that a prolonged substantial inhibition of 
protox in all tissues is still compatible with life.  
 
1.6  Physical and Chemical and Environmental Fate Properties 
Several important physical, chemical, and fate and transport property values for flumioxazin are 
listed in Table 2.2 (USEPA, 2011B). The environmental fate of flumioxazin is characterized by 
rapid hydrolysis, photolysis, and aerobic metabolic degradation in soil and water. It has moderate 
mobility in soils, while its three major degradates are expected to be more mobile. Flumioxazin 
is expected to volatilize slowly from water and wet surfaces based on its Henry’s law constant 
value. It is not expected to accumulate in fish based on its octanol-water partitioning constant 
(KOW). More detailed information from EPA documents (USEPA, 2008 and USEPA 2011B) on 
the environmental fate properties is described below. 
  
1.6.1 Hydrolysis 
Flumioxazin hydrolyzes very rapidly in water. The hydrolysis rate increases as the pH of the 
solution increases. The average half-lives in hydrolysis studies with radio-labeled flumioxazin 
were 4.2 days, 23 hours, and 18.3 minutes for pH 5, 7, and 9 buffered solutions, respectively. 
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Four degradates were observed: 7-Fluoro-6[(2-carboxy-cyclohexenoyl)amino]-4-(2-propynyl)-
1,4-benzoxazin-3(2H)-one (482-HA), 6-Amino-7-fluoro-4-(2-propynyl)-1,4,-benzoxazin-3(2H)-
one (APF), 3,4,5,6-tetrahydrophthalic acid (THPA), and 3,4,5,6-Tetrahydrophthalic acid 
anhydride (∆-TPA). Degradate 482-HA was found at high concentrations (97.3% of the applied) 
in the solution with pH 9. APF and THPA were not detected in the pH 9 solutions, but were 
important components in the pH 5 and 7 solutions (40-48%). ∆-TPA was a minor component 
(8.8% of the applied) in the pH 5 and 7 solutions. At the end of a 30-day hydrolysis study, the 
parent and major degradates were detected at the following percentages of applied radioactivity 
(at pH 7): flumioxazin at 4.7%, 482—HA at 9.3 %, APF at 40.0%, and THPA at 41.8%.  
 
1.6.2 Photolysis 
 
Flumioxazin degrades rapidly by photolysis in water. The half lives observed in three irradiation 
studies with differently radio-labeled flumioxazin that were reviewed and described by USEPA 
(2011B) were in the range of <1 to 26.3 hours. The results of the photolysis studies were 
summarized by stating that flumioxazin can degrade quickly via photolysis to 482-PHO (no 
chemical description for this and the following degradates available) which degrades to either 
482-PHO-HA or 482-PHO-DC; 482-PHO can also degrade to 482-PHO-ISO which becomes 
482-PHO-APF, or 482-PHO can degrade directly to 482-PHO-APF as can 482-PHO-HA; 482-
PHO-ISO can degrade to both 482-PHO-HA and 482-PHO-DC which can further degrade to 
THPA. Further degradation occurs forming CO2 and minor polar degradates. Shibata et al. (2011) 
identified two photo degradates: N-(2-propynyl)-4-[4-carboxy-3-fluoro-2-(3,4,5,6-
tetrahydrophthalimido)-2-butenylidene]azetidine-2-one which can transform to N-(2-propynyl)-4-
[4-carboxy-3-fluoro-2-(2-carboxy-1-cyclohexenecarbonylamino)-2-butenylidene]azetidine-2-one. 
The latter one degrades to THPA and CO2 plus bound residues. 
The half lives for the parent compound flumioxazin observed  in two irradiation studies with 
differently radio-labeled compounds were 3.2 and 8.4 d, with various degradates identified 
(USEPA, 2011B).  
 
1.6.3 Biotic Degradation 
Aerobic soil metabolism studies in California sandy loam soils incubated with labeled 
flumioxazin showed half-lives of 11.9 and 17.5 days. Four minor degradates were detected (482-
CA, 482-HA, APF, and IMOXA). Soil-bound residues increased to 74% of the applied dose by 
day 181.  Studies with unlabeled flumioxazin in various soil types showed half-lives in the range 
of 5.0 to 18.9 days. Degradates were not monitored. Under anaerobic conditions, labeled 
flumioxazin degraded with half-lives of 4.2-4.3 hours in a flooded sandy loam. Major degradates 
identified were 482-HA and SAT-482-HA-2.  
Anaerobic metabolism in aquatic systems was studied in a pond water-clay sediment system 
from Mississippi for 360 days in darkness. Radio-labeled residues appeared to rapidly partition 
into the sediment, in both labels, during the early part of the study. However, over the course of 
the study, the partitioning was variable in the [phenyl-14C]-label, with the majority of the 
radioactivity in the sediment at 360 days, while radioactivity in the sediment of the [THP-14C]-
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labeled flumioxazin steadily declined, with the majority of the radioactivity in the water at 360 
days. The significance of this difference was not further addressed in the review by USEPA. In 
the [phenyl-14C]-flumioxazin, the water:sediment ratio was approximately 1:3 from 0 to 7 hours, 
1:1 at 1 to 3 days, 1:3 at 21 days, and finally 1:5 at 360 days (study termination). In [THP-14C]-
flumioxazin, the water:sediment ratio was approximately 1:3 at 0 to 7 hours, 1:1 at 1 to 21days, 
1:0.5 at 42 days, and finally 1:0.3 at 360 days. Based on first-order linear regression analysis, 
flumioxazin in the total system (combined labels) dissipated with a calculated half-life of 42.8 
days; the individual half-lives were 45.9 and 40.1 days for the phenyl and THP labels (0-360 
days), respectively. It should be noted that these half-life values seem very high based on the 
degradation data from which they seemed to have been calculated. In the same section, 
dissipation data for flumioxazin indicate much faster degradation. In the [THP-14C]flumioxazin, 
flumioxazin in the total system decreased from 90.4% of the applied concentration at time 0, to 
85.7% at 7 hours, 38.5% at 1 day, 12.1% at 21 days, 0.4% at 268-360 days. In the [phenyl-
14C]flumioxazin solutions, flumioxazin in the total system decreased from 98.7% of the applied 
concentration at time 0, to 89.0% at 7 hours, 41.9% at 1 day, 24.1% at 10 days, 2.6% at 59 days, 
and was 0.48% at 360 days (study termination). A much lower value for anaerobic metabolism 
half-life values was reported in an earlier EPA factsheet: a half-life of 0.2 d for anaerobic aquatic 
metabolism (USEPA, 2001).   
The aerobic aquatic metabolism was studied in stream water-clay loam sediment (water pH 7.80, 
dissolved organic carbon 16.8 mg/L; sediment pH 7.28-7.7, organic carbon 8.0%) and lake 
water-sandy clay loam sediment (water pH 6.32, dissolved organic carbon 16.9 mg/L; sediment 
pH 5.3-6.4, organic carbon 3.6%) systems from the United Kingdom for 98 days under aerobic 
conditions in darkness at 20 °C. Labeled flumioxazin ([phenyl-U-14C]- and [tetrahydrophthaloyl 
(THP)-1,2-14C]) dissipated at similar rates in the two sediment systems. Summaries of these 
studies are available in the EPA review document (USEPA, 2011B). Calculated  non-linear half-
lives were 2 hours, 42-53 days and 3-5 days in the water layers, sediments and total systems, 
respectively. 
 
1.6.4  Mobility of Flumioxazin 
 USEPA concludes that the overall potential for the parent compound to migrate into ground 
water and to move with surface runoff water is low. However, based on the organic carbon 
adsorption coefficients (KOC) obtained from column leaching studies, flumioxazin can be  
classified as a chemical with “moderately mobile” soil mobility potential (mean KOC = 557) 
(USEPA, 2013). Based on vapor pressure 3.2 mPA (25 °C), flumioxazin is classified as volatile. 
Based on its Henry’s Law constant value of 6.32 x 10-2 Pa m3 mol-1 (25 °C) flumioxazin is classified 
as non-volatile.1  
 
1.6.5 Mobility of 482-HA, APF and THPA 
 No mobility information on 482-HA was available. Based on its chemical structure, this 
degradate is expected to be more mobile in alkaline environments than in acidic ones. No further 
                                                 
1
 Pesticide Properties DataBase (PPDB): http://sitem.herts.ac.uk/aeru/iupac/335.htm 
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absorption studies for 482-HA have been required by USEPA because it was found in the pH 7 
hydrolysis study at a much lower level than the other two degradates (APF and THPA). APF and 
THPA were classified by USEPA as “moderately mobile” based upon adsorption study results 
(APF KOC values in the range of 201 to 620; THPA KOC values in the range of 13 to 191). 
1.6.6 Bioconcentration 
EPA granted a waiver for a bioconcentration study based on the following considerations: 1) the 
observed octanol/water partition coefficient is smaller than 1,000 (log Kow = 2.55); and 2) 
degradation is rapid in water with a half-life of about one day at pH 7 and about 20 minutes at 
pH of 9. Based on the low octanol water partition coefficient flumioxazin is not expected to 
accumulate in fish. According to a fish residue study submitted to EPA, BCFs between the edible 
tissue in bluegill and catfish and the static water treated with 800 µg/L flumioxazin during the 
seven samplings in the exposure period of 28 days ranged from 0.09-4.1 for flumioxazin, 0.2-1.3 
for APF, and 0.04-2.6 for 482-HA. It should be noted that BCFs may be underestimated based on 
results of static water tests. 
 
Table 1.1. Physical and Environmental Fate Properties of Flumioxazin (USEPA, 2011B) 
Property Value 
CAS number 103361-09-7 
Molecular weight 354 
Molecular formula C19H15FN2O4 
Water solubility (mg/L) 1.8 
Log Kow 2.55 
Vapor pressure at 25oC (mmHg) 2.46 ×10-06 
Henry’s Law constant at 25oC (atm⋅m3⋅mol-1) 6.36 ×10-07 
Soil adsorption coefficient KOC (L/kg) based on 
column leaching studies 112, 271, 656, 1190 
Soil adsorption coefficient KOC (L/kg) based on 
adsorption study 13, 66, 75, 191, 248, 339 
Hydrolysis half-life (d) 
 pH = 5 
 pH = 7 
 pH = 9 
 
4.2 
1 
0.01 
Photolysis half-life in water, pH 5 (d) 1 
Aerobic aquatic metabolism half-life (d) 3-5 
Anaerobic aquatic metabolism half-life (d) 40.1 and 45.91 
Fish bioconcentration factors The bioconcentration factor for the 
inedible tissue was <1X. 
In edible portions, BCF was 0.9-4.1 
1
 A much lower value of 0.2 d was reported in USEPA (2001) 
1.6.7 Metabolism Pathways  
Two metabolism pathways in the aquatic environment have been proposed. In anaerobic 
conditions, flumioxazin degraded rapidly via hydrolysis of the phthalimide group to form 482-
HA which further degraded to THPA and APF (Fig. 1.2). A second degradation pathway 
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proceeded via reduction of the cyclohexene double bond in 482-HA to form SAT-482-HA. It 
was also stated that it was possible, but unlikely that reduction preceded hydrolysis. THPA 
degraded to HPA by reduction of the double bond in THPA or hydrolyzed (Michael type 
reaction) to 1-OH-HPA. The side chain alkyne in APF was reduced to DAPF. Degradation 
continued to form multiple polar fragments, sediment-bound  residues, methane and CO2.Under 
aerobic conditions, the primary pathway involved hydrolytic cleavage and separation of the 
phthalimido and benzoxazin moieties at the amine bridge to yield APF and THPA. Other 
products identified included ∆-TPA, SAT-482-HA-2, IMOXA, 482-HA, 482-CA, and SAT-482. 
Mineralization to CO2 occurred with both moieties, but was most significant with the 
phthalimido moiety. Formation of bound sediment residues was significant for both moieties. 
1.6.8   Degradate Profile 
 Twelve degradates were detected in various laboratory abiotic and biotic fate studies. The major 
degradates are 482-A, APF, THPA, ∆-TPA, adipic acid, 482-PHO, 482-PHO-ISO, 482-PHO-
DC, SAT-482-HA-2, DAPF, SAT-482-HA, HPA, and combined residues of THPA+ ∆-TPA. 
USEPA concluded that hydrolysis is a major route of dissipation for flumioxazin in the 
environment especially in alkaline aqueous media (half-lives = 4.2, 1, and 0.01 days, 
respectively, at pH 5, 7, and 9). As a result, the three major degradates generated with hydrolysis 
(APF, THPA, and 482-HA) are expected to occur as the major degradates in the environment 
and were considered in the human health and ecological risk assessments in this document.  
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Figure 1.2. Proposed degradation pathway of flumioxazin in an aquatic anaerobic metabolism system (USEPA, 
2011B) 
 
A recent study provides additional information and insights into the aerobic aquatic dissipation 
and degradation profile of flumioxazin (Shibata et al., 2011). Water and sediments were 
collected from a pond in Japan and a lake in the UK and were used in laboratory-scale systems 
consisting of water or water plus sediments under illumination and in darkness. Flumioxazin was 
rapidly degraded in the overlying waters irrespective of illumination with half-lives of 0.1-0.4 
days. Four major degradates were formed under illumination. The degradates 482-HA and THPA 
were formed through successive hydrolysis. Two other degradates (2-arizidinone derivatives) 
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were formed via photo-induced rearrangement. The presence of sediment under illumination 
greatly reduced the formation of these degradates and accelerated their degradation. The 
degradate APF was only detected as a minor fraction in one of the studied systems. The 
degradation profiles of flumioxazin in an illuminated water-sediment system are shown in Fig. 
1.3 and Fig. 1.4. After 30 days, 50% of the applied radioactivity was present in the sediment 
phase and 17.3% was present in the water phase and 7.5% in the gas phase (CO2), adding up to a 
total of 80.9% that was accounted for. The authors did not comment on this difference, but in 
comparison with their other studied systems, the fraction in the gas phase seems to be low in the 
system displayed in Fig. 1.3 and Fig. 1.4.  
 
 
Figure 1.3. Distribution of 14C-labeled flumioxazin and degradates in the water phase of the illuminated water-
sediment system (Calwich Abbey system) generated based on data in Table 7 in Shibata et al. (2011). Symbols are 
the data points and smoothed lines were added to highlight trends.  
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Figure 1.4. Distribution of 14C-labeled flumioxazin and degradates in the sediment phase of the illuminated water-
sediment system (Calwich Abbey system) generated based on data in Table 7 in Shibata et al. (2011). Symbols are 
the data points and smoothed lines were added to highlight trends. 
 
1.6.9  Field Dissipation Studies 
The environmental fate laboratory studies results indicate that the major routes of dissipation of 
flumioxazin in the environment appear to be rapid hydrolysis, photolysis, and metabolism of the 
parent compound. Field dissipation in soil was evaluated in field plots in Mississippi (silt loam), 
Illinois (silt loam), Iowa (silt loam), North Carolina (loamy sand), Indiana (loam soil) and 
California (soil type not reported). The application rates were in the range of 42-45 g 
flumioxazin /acre, except on the plot in California where the rate was 182 g flumioxazin/acre. 
The median of the half-lives was 12.5 days (range of 4.8 to 42 days). Flumioxazin generally did 
not leach below the 0- to 3-inch top soil layer, except for a single detection in the 3-6 inch depth 
layer in the Iowa plot. On the plot in California there were two detections in the 3-6 inch depth 
layer and a single detection in the 6-12 inch depth layer.  
The aquatic field dissipation of flumioxazin was studied using a pond at one site in Iowa 
(average depth not specified; volume, 2.54 acre/ft) and a 0.469-acre pond at one site in Florida 
(average depth, 4 ft; volume, 1.88 acre/ft). These studies were conducted by the registrant of 
flumioxazin (MRID 47550605). Water and sediment samples were collected from each test site 
at 0-2 hours, 12-14 hours, and at approximately 1, 3, 5, 7, 14, 28, 60, and 90 days post-treatment. 
Pond water samples were collected at three depths: at 1 foot below the water surface, at mid 
depth, and at 1 foot above the pond bottom. Sediment samples were collected to a depth of 10 
cm. Water and sediment samples were analyzed for flumioxazin and the two transformation 
products 482-HA and APF. The results from the Iowa study were available in EPA’s review 
document and are summarized below.  
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40
P
e
rc
e
n
ta
g
e
 o
f 
A
p
p
li
e
d
 R
a
d
io
a
ct
iv
it
y
Time (days)
Flumioxazin
482-HA
THPA
Photo_5
Photo_6
Unknown
Total Bound Residue
Sediment Phase
  
MDAR/MassDEP 10 June 2013 
 
 The concentration profiles in water phase are shown in Fig. 1.5. It was not stated what the 
initially applied concentration was, but from the available information it can be inferred that the 
applied concentration likely must have been 400 µg/L (233 µg/L is 58.3% of 400). The measured 
levels of 482-HA of more than 300 µg/L are only possible with an initial concentration of higher 
than 233 µg/L).  
The half-life of flumioxazin was not reported. 482-HA had a reviewer-calculated linear, first-
order half-life value of 4.9 days (r2 = 0.94), and a nonlinear (one-compartment/two-parameter) 
half-life value of 2.6 days (r2 = 0.98) in pond water, calculated based on the reviewer-calculated 
means across all sampling depths (0-28 day data). APF had a reviewer-calculated linear, first-
order half-life value of 10.5 days (r2 = 0.63), and a nonlinear (one-compartment/two-parameter) 
half-live value of 2.7 days (r2 = 0.97) in pond water, calculated based on the reviewer-calculated 
means across all sampling depths (0-28 day data). 
 
Figure 1.5 Concentrations of flumioxazin and degradates 482-HA and APF observed in the water phase of a pond in 
Iowa 
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Figure 1.6. Concentrations of flumioxazin and degradates 482-HA and APF observed in the sediment phase of a 
pond in Iowa 
 
The concentration profiles in sediment phase are shown in Fig. 1.6. 482-HA had a reviewer-
calculated linear, first-order half-life value of 3.3 days (r2 = 0.08), and a nonlinear (one-
compartment/two-parameter) half-live value of 2.5 days (r2 = 0.63) in pond sediment, based on 
all replicate concentration data which occur on intervals with replicate values above the LOQ 
(0.5-7 days; replicate values below the LOQ were assumed at ½ LOQ). The transformation 
product APF was not detected in the pond sediment above the LOQ at any sampling intervals. 
The registrant provided a field study conducted in two water bodies in the state of Michigan 
during 2011 (Fausey, 2011). The persistence of flumioxazin was monitored and the performance 
of this herbicide was evaluated. Selected areas in the two lakes with a depth of 5 feet were 
treated with 200 µg/L of flumioxazin. Water samples were taken at 0, 1, and 24 hours after 
treatment and were analyzed. The results showed that flumioxazin levels had declined to levels 
below 50 µg/L 24 hours after treatment.   
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2 Human Health Risk Assessment 
 
The Health Effects Division (HED) of EPA conducted a risk assessment in conjunction with the 
registration of aquatic use for flumioxazin (USEPA, 2010C). That document was also the 
primary source of information for the registration review scoping document (USEPA, 2011C). 
These risk assessment documents are based on registrant-submitted studies which are generally 
not released or made available to individuals outside of the EPA Office of Pesticides. 
Summarized below are the hazard characterization and endpoint selection, assessments for 
dietary risk, risk associated with recreational use, and a drinking water assessment.  
 
 
2.1. Hazard Characterization and Toxicity Endpoint Selection 
Flumioxazin exhibited mild or no acute toxicity (categories III and IV) by oral, dermal and 
inhalation exposure routes. It also is classified in the same categories for primary eye and skin 
irritation and is not a dermal sensitizer. Subchronic and chronic toxicity studies demonstrated 
that toxic effects of flumioxazin exposure include anemia, and effects on the liver and the 
cardiovascular system. Developmental effects were observed in rat studies, but not in rabbit 
studies.  
 
In utero exposure to flumioxazin  has been associated with developmental and reproductive 
toxicity in rats.  In one oral gavage developmental study with rats, animals were dosed daily on 
gestation days 6-15 at  with 1,3,10 and 30 mg/kg study (Kawamura et al., 1995). No maternal 
effects were seen in the study. Developmental toxicity was seen at 30 mg/kg including 
significant increases in ventricular septal defects (VSD), embryolethality and skeletal defects 
(curvature of the scapula and wavy ribs) and decreased fetal growth.    
 
The same study included a mechanistic study to identify the sensitive period during gestation to 
the herbicide. Rats were given single doses of 400 mg/kg on one of gestational days 11-15. The 
highest incidences of embryonic death and VSD and reduction of fetal body weight occurred 
when dosing took place on day 12.  
 
In a dermal prenatal developmental study, no maternal effects were seen at the highest dose 
tested (300 mg/kg/day), but effects in fetuses were observed at a dose of 100 mg/kg/day. The 
effects were fetal cardiovascular anomalies, especially ventricular septal defects. Information on 
dosing regime was not available in EPA’s summary document.  
 
In a 2-generation reproduction study, systemic effects were observed in adult animals at the 
highest doses tested (HDT) of 18.9 mg/kg/day in males and 22.7 mg/kg/day in females. The 
observed effects included clinical signs and mortality as well as a decrease in body weight and 
body weight gain, and in food consumption. Offspring effects were also observed and included 
decreased pup body weights, a decrease in the number of live born, decreased mating index, and 
testicular atrophy in F1 males. Information on dosing regime was not available in EPA’s 
summary document. 
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In contrast to the studies with rats, there was no evidence of susceptibility to developmental 
toxicity in rabbit studies. The absence of effects in rabbits was supported by literature studies 
indicating that rabbits are less susceptible to effects of PPO inhibitors.  
 
No neurotoxicity studies are available. The review by the U.S. EPA Hazard Identification 
Assessment Review Committee stated that the acute, subchronic, chronic, developmental and 
reproduction studies did not indicate that flumioxazin had an effect on the nervous system 
(USEPA, 2004). According to new data requirements which became effective in 2007, 
neurotoxicity studies must be submitted. These studies will be required with registration review 
(USEPA, 2010C).   
 
Flumioxazin was classified as “not likely to be a human carcinogen”. This assessment was based 
on studies with rats and mice that indicated that flumioxazin did not induce significant increases 
in any tumor type in either rats or mice. In addition, it did not exhibit any mutagenic activity.  
 
Flumioxazin is extensively excreted with urine and feces. Metabolism studies in rats indicated 
that recovery of flumioxazin in feces and urine was over 90%, with 4 – 5 times more excreted in 
feces than in urine. Highest levels of residues were found in blood cells (35.9-48.8 µg/L), which 
was much higher than the plasma levels (0.5-0.7 µg/L). In addition to untransformed parent 
compound, 7 metabolites were identified in urine and feces.  
 
The EPA selected cardiovascular effects observed in oral developmental and pre-natal studies in 
rats as the basis for their acute dietary risk assessment. This endpoint is only applicable to 
females of child-bearing age (i.e., females of 13-49 years of age). The acute oral reference dose 
(aRfD) of 0.03 mg/kg was established for females in the 13-49 age group based on a NOAEL of 
3 mg/kg for cardiovascular defects in rat fetuses seen at a LOAEL of 10 mg/kg. No acute oral 
endpoint was identified in the database for children or the general population. A chronic 
reference dose (cRfD) of 0.02 mg/kg/day was established for all populations based on a NOAEL 
of 2.0 mg/kg/day for increased chronic nephropathy in males and decreased hematological 
parameters in females. A NOAEL of 30 mg/kg/day from a rat dermal development toxicity study 
was selected for short- and intermediate-term dermal risk assessments for adults. For children 
exposed via the dermal route, the NOAEL of 6.3 mg/kg/day from the rat reproduction study was 
selected for risk assessment. For short- and intermediate oral exposure, the NOAEL of 6.3 
mg/kg/day for reproduction and fertility effects in rat was selected as the dose for risk 
assessment. Since dosing information is not available in EPA’s summary document, the dose 
units reported above cannot be verified.  
 
Although the developmental and reproductive toxicity studies indicated that there was an 
increase in susceptibility for effects, HED’s degree of concern for the susceptibility observed in 
the rat developmental and reproductive studies is low. This is because the regulatory endpoints 
for flumioxazin are based on clear no-observable-adverse-effect-levels (NOAELs) for 
developmental and reproduction studies. Doses and endpoints for risk assessment were chosen to 
be protective of cardiovascular and hematopoietic effects. It was concluded that there are no 
residual concerns for these effects. There are data that indicate differential species sensitivities to 
PPO chemicals. The Kawamura (1995) study showed a 100x difference in sensitivity between 
rats and rabbits (the insensitive ones for D/R toxicity). Pauli and Kennedy (2005) looked at 
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another endpoint (porphyria) using another herbicide having the same mechanism of action as 
flumioxazin and noted major differences in species sensitivities:(rats and hamsters were not 
affected whereas lab mice were strongly affected. Field mice and meadow voles were not 
affected. The authors concluded that the lab mouse strain was unique in its sensitivity to this 
herbicide.   
 
2.2 Risk Associated with Recreational Uses of Water Bodies  
Since there is no label restriction for swimming in treated water bodies, there is potential for 
exposure to flumioxazin with recreational activities. EPA used the SWIMMODEL to assess short-
term post-application exposures and risks for children and adults. The SWIMMODEL uses well-
accepted screening-exposure assessment equations to calculate the total worst-case exposure for 
swimmers expressed as a mass-based intake value (mg/event). The model considers dermal and oral 
exposures. The assessment was based on an exposure concentration of 400 µg/L. A margin-of-
exposure (MOE) of 100 is considered sufficient to protect swimmers. The swimmer assessments 
indicated that all MOEs are above the level-of-concern (LOC) of 100 with values of 2,300 and 
15,000 for oral and dermal exposure to a child, respectively. For an adult these values were 3000 and 
84,000, respectively.  
 
There are no label fishing restrictions in treated water and no fish consumption restrictions. 
Flumioxazin residues were measured in edible fish tissues (bluegill and channel catfish) over a 28-
day period of exposure after flumioxazin application at 800 µg/L, which is equal to two times the 
maximum aquatic application rate of 400 µg/L. Total residues measured at the earliest sampling 
interval of 4 hours were 0.85-2.52 mg/L. Total residues declined rapidly by day 3 and then remained 
relatively steady up to day 28 in the range of 0.063-0.204 mg/L. Flumioxazin did not bioaccumulate 
in fish over the 28-day study. A tolerance of 1.5 mg/L has been established for freshwater fish. The 
data above indicate that the range of sampling results from the earliest sampling interval 
encompasses levels that exceed the tolerance of 1.5 mg/L. However, it seems unlikely that total 
residues of flumioxazin in fish would reach or exceed the tolerance level when the commonly used 
application rate of 200 µg/L is employed which is approximately 0.25 of the level used in the 
reported experiment. 
 
Aggregate risk was assessed by combining residential exposures from swimming and handlers 
applying the herbicide for weed control with chronic dietary exposure. The MOE for adults was 694 
and 470 for children. These exposure levels are above the LOC of 100 and aggregate risk is therefore 
not of concern. 
 
 
2.3 Drinking Water Assessment 
The drinking water residue profile was characterized by estimation of environmental 
concentrations of flumioxazin and its major degradates (482-HA, APF and THPA) in surface 
water following the application of flumioxazin  (USEPA, 2010B). Ground water concentrations 
were not estimated by EPA since they judged the potential for flumioxazin to reach groundwater 
as low.   Based on their Koc, the potential for APF and THPA to leach to groundwater is higher 
than the parent compound. However, the mobility of flumioxazin’s major degradation product 
(482-HA) detected in the hydrolysis and the unidentified residues detected in the aqueous 
photolysis and anaerobic aquatic metabolism studies is unknown. These residues may persist in 
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the environment and may leach to groundwater.   
 
Water concentrations of flumioxazin and its hydrolysis degradates 482-HA, APF, and THPA 
were estimated for the highest proposed aquatic use level of 400 µg/L of flumioxazin in a treated 
water body, six applications per year at an application interval of 28 days. The chronic EECs of 
flumioxazin and its degradates during a period of one year were calculated based on hydrolysis 
parameters for breakdown of the parent and formation the degradates. Since metabolism and 
field studies indicated that the degradates were not persistent, the degradate EECs would 
represent the worst case scenario.  
 
THPA was not included in the residue of concern for drinking water because it was expected to 
have significantly lower toxicity than the parent and the other degradates. EPA did not provide 
further information or data to support this decision. For the purpose of the review presented here, 
information on the toxicity of flumioxazin and the three degradates was generated through the 
use of TOXTREE software 2. TOXTREE is an application which is able to estimate toxic hazard 
and places chemicals into categories by applying a decision tree approach. The evaluation of 
flumioxazin and its degradates was done based on the option using the Cramer classification 
scheme which places compounds into one of three classes. Flumioxazin, 482-HA and APF were 
identified as Class III substances, which are those that permit no strong initial presumption of 
safety, or may even suggest significant toxicity or have reactive functional groups. THPA was 
identified as a Class I substance which are simple chemical structures with efficient modes of 
metabolism suggesting a low order of oral toxicity. These results support the decision by EPA to 
not include THPA in the drinking water assessment based on lower toxicity.  
 
 The acute exposure concentration used in EPA’s assessment was 400 µg/L based on the initial 
concentration of flumioxazin immediately following the application. The total EEC at day 30 and 
after was calculated at 142 µg/L (10.4 µg/L flumioxazin + 21.6 µg/L 482-HA + 110.1 µg/L 
APF) as an estimated total residue level for chronic exposure. This represents a worst-case 
scenario for aquatic exposure levels.  
 
For the purpose of this review, the risk of exposure through drinking water was assessed by 
comparing the EECs of flumioxazin to human health benchmarks that have been established for 
this active ingredient. These human health benchmarks for pesticides are levels of certain 
pesticides in water at or below which adverse health effects are not anticipated from one-day or 
lifetime exposures. EPA developed the human health benchmarks for pesticides to enable states, 
water systems and the public to better determine whether the detection of a pesticide in drinking 
water or source waters for drinking water may indicate a potential health risk (USEPA, 2012C).  
For flumioxazin, the acute benchmark value is 999 µg/L and 140 µg/L for chronic exposures. 
The acute value is based upon the prevention of developmental cardiovascular defects.  
 
The assumed acute EEC of 400 µg/L is less than half of the acute benchmark value. The chronic 
EEC for flumioxazin of 10.4 µg/L is also much lower than the benchmark. However, the 
degradates APF and 482-HA are assumed to have similar toxicity to that of the parent. The total 
                                                 
2
 TOXTREE was developed for the European Commission’s Institute for Health and Consumer Protection. 
Information  is available at: http://toxtree.sourceforge.net/  
  
MDAR/MassDEP 16 June 2013 
 
EEC of 142 µg/L is therefore similar to the chronic benchmark. It should be pointed out that the 
EECs used by EPA represent worst-case scenarios assuming frequent applications and 
persistence of degradates. Field dissipation studies have indicated chronic residues are lower. For 
example, the dissipation data from a pond in Iowa (see Section 2.4) at day 7 showed 15.6 µg/L 
flumioxazin, 32.9 µg/L 482-HA and 1.99 µg/L APF, which makes a total of 50.5 µg/L.  We 
modeled expected EECs for the typical single application concentration of 200 µg/L (Section 
3.2.1) and projected a total 21-d average residue of 74.9 µg/L (sum of flumioxazin, 482-HA and 
APF concentrations) and a total 60-d average residue of 30.8 µg/L; both well below their 
respective duration specific benchmarks. 
 
For groundwater exposure, one can consider a conservative screening-level scenario of the 
recharge of groundwater with surface water with no attenuation resulting in groundwater EECs 
with the same values as presented above for treated surface water.  
 
The comparison of expected levels in water bodies and human health benchmark values indicate 
that effects on human health are unlikely to occur from exposure via drinking water containing 
residues of flumioxazin from aquatic applications.  
 
 
 
2.4.  Deficiencies and Data Gaps  
HED has evaluated the status of the human-health assessments for flumioxazin to determine 
whether sufficient data are available and whether any updates are needed to support Registration 
Review (USEPA, 2011A). The Agency anticipates that acute and chronic neurotoxicity studies 
as well as an immunotoxicity study will be required to support registration review. These studies 
are new data requirements for pesticides. In addition, an inhalation study is required to fully 
characterize the toxic effects resulting from this route of exposure. Multi-residue Methods 
Testing for flumioxazin and water degradates 482-HA and APF are also required.  
Aggregate assessments will be updated to include any changes that have been made in 
toxicological endpoints, or exposure estimates. Revised assessments will be conducted for all 
scenarios based on updated points of departure and procedures for ingestion, dermal and 
inhalation risk assessment. 
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3.0  Ecological Risk Assessment 
USEPA conducted an ecological risk assessment as part of the evaluation associated with the 
registration for the use of flumioxazin to control vegetation in aquatic sites (USEPA, 2010A). The 
flumioxazin analysis consisted of assessment of exposure concentrations, and evaluating toxicity 
information to characterize potential risks to non-target species in the environment.  The analysis 
is based on a screening-level assessment of estimated exposure concentrations combined with 
information from flumioxazin toxicity studies.  
 
3.1 Ecological Hazard Characterization  
The risk assessment document by USEPA (2010A) summarizes the effects characterization for 
flumioxazin as described below.  
 
3.1.1 Toxicity to Aquatic Animals 
 
Table 3.1 summarizes the toxicity data for aquatic animals. The data from the various categories 
of aquatic animals are described below. 
 
Freshwater Fish: In acute toxicity studies conducted on coldwater and warm-water species, the 
96-hour LC50 values for the technical grade material ranged from 2.3 to > 21 mg/L, suggesting 
that flumioxazin will be moderately to slightly acutely toxic to freshwater fish. An early life-
stage toxicity test conducted on rainbow trout showed that flumioxazin significantly affected 
larval growth (length and weight) at concentrations with a lowest-observable-adverse-effect-
concentration (LOAEC) of 16.0 µg/L and a no-observable-adverse-effect concentration 
(NOAEC) of 7.7 µg/L. Standard toxicity testing may not include light with the same wavelength 
or intensity as natural sunlight. LDPHs may be more toxic when exposed to natural sunlight, such 
as exposure conditions in the field. EPA has requested studies to address this uncertainty.   
 
EPA typically uses fish as a surrogate for aquatic-phase amphibians when aquatic-phase 
amphibian toxicity data are not available. While EPA does not make reference to specific data in 
support of this practice, several reviews of acute and chronic toxicity data in the literature 
indicate that this approach is justified in most cases (Mayer and Ellersieck, 1986; Kerby et al., 
2010; Weltje et al., 2013).  
 
Freshwater Invertebrates: Acute toxicity studies conducted on freshwater aquatic invertebrates 
suggest that the active ingredient flumioxazin is moderately toxic. The 48-hour LC50 or EC50 
value was 5.5 mg/L. The chronic data indicate that flumioxazin significantly reduced 
reproduction at concentrations equal to a LOAEC of 57 µg/L and a NOAEC of 28 µg/L and 
survival and growth (length and weight) at concentrations equal to 107 µg/L (LOAEC) and 57 
µg/L (NOAEC). 
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 Table 3.1 Toxicity of Flumioxazin to Aquatic Animals 
Freshwater Fish Acute Toxicity 
Species 96-hour LC50 (mg/L) Toxicity Category  
Rainbow trout 
(Oncorhynchus mykiss) 2.3 Moderately toxic 
 
Rainbow trout 
(Oncorhynchus mykiss) >2.4 (OECD 21-day test) Moderately toxic 
 
Bluegill sunfish  
(Lepomis macrochirus) > 21.0 Slightly toxic 
 
Freshwater Fish Early Life-Stage Toxicity Under Flow-through Conditions 
Species NOAEC/LOAEC (µg/L) MATC1 (µg/L) Endpoints Affected 
Rainbow trout 
(Oncorhynchus mykiss)  7.7/16.0 11.0 Growth (length and wt.) 
Freshwater Invertebrate Acute Toxicity 
Species 48-hour LC50/ EC50 (mg/L) Toxicity Category 
 
Waterflea 
(Daphnia pulex) 5.5 Moderately toxic 
 
Freshwater Invertebrate, Chronic 
Species 
21-day 
NOAEC/LOAEC (µg/L) 
MATC1 (µg/L) Endpoints Affected 
Waterflea 
(Daphnia magna) 28.0/57.0 40.0 
Reproduction, survival and 
growth 
Estuarine/Marine Fish and Invertebrates Acute Toxicity 
Species 96-hour LC50 (mg/L) Toxicity Category  
Sheepshead minnow 
(Cyprinodon variegatus) >4.7 Moderately toxic 
 
Eastern oyster  
(Shell deposition) 
(Crassostrea virginica) 
2.4 Moderately toxic 
 
Mysid 
(Mysidopsis bahia) 0.23 Highly toxic 
 
Estuarine/marine Aquatic Invertebrate Life-Cycle Toxicity 
Species 
21-day 
NOAEC/LOEAC (µg/L) 
MATC1  
(µg/L) 
Endpoints Affected 
Mysid (Mysidopsis bahia) 15.0/27.0 20.0 Reproduction, survival and growth 
1
 Maximum Allowed Toxic Concentration, defined as the geometric mean of the NOAEC and LOAEC 
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Estuarine/Marine Fish: Testing on sheepshead minnow resulted in a 96-hour LC50 of  >4.7 
mg/L, which is considered to be moderately acutely toxic. No data were submitted to assess 
chronic risk to estuarine/marine fish. 
 
Estuarine/Marine Invertebrates: Acute toxicity testing on estuarine/marine invertebrate species 
with the technical product resulted in 96-hour LC50 /EC50 values ranging from 2.4 to 0.23 mg/L 
which fall into the moderate to highly toxic acute classes for estuarine/marine invertebrates. The 
chronic data indicate that flumioxazin significantly reduced reproduction and growth (length and 
weight) at concentrations equal to 27 µg/L (LOAEC) and 15 µg/L (NOAEC) and survival at 
concentrations equal to 55 µg/L (LOAEC) and 27 µg/L (NOAEC). 
 
Given that flumioxazin has been shown to produce developmental effects after exposure during 
one critical day early in the developmental stage in mammals, and given the similarities in 
developmental phases across all gestational organisms, developmental toxicity could actually be 
produced acutely in other aquatic species.  Though this would be difficult to demonstrate given 
the types of tests typically conducted to assess toxicity, the developmental information showing 
this acute developmental toxicity for this chemical is noteworthy. 
 
 
3.1.2  Toxicity to Terrestrial Species 
 
Mammalian Species: Laboratory studies with rats indicated that flumioxazin was practically non-
acutely lethal to small mammals with oral exposure (LD50 of 5000 mg/kg). Results from a chronic 
2-generation reproduction study with rats at dietary levels of 0, 50, 100, 200, and 300 mg/kg 
indicate reproductive toxicity at a LOAEL of 200 mg/kg (NOAEL of 100 mg/kg) with decreased 
number of live-born pups and decreased pup weights.  Increases in the incidence of reproductive 
organ abnormalities (predominately atrophied or hypoplastic testes and/or epididymides) were 
also noted that may imply an endocrine modulated pathway. Absolute organ weight for the testes, 
epididymides and prostate were significantly reduced at 300 mg/kg for F1 males. There was also 
decreased mating index and testicular atrophy in F1 males. 
 
A more complete summary of mammalian toxicity studies was provided in Section 2.1, including 
identification of key rat studies used by the USEPA for identification of acute and chronic 
toxicity values (NOAELS of 0.3 and 0.2 mg/kg respectively) which can be used as the basis for 
identifying reference doses for terrestrial species derived from the rat data. Avian Species: In an 
acute oral toxicity study conducted on bobwhite quail, the LD50 for the technical product is >2250 
mg/kg. The results suggest that flumioxazin is practically non-acutely toxic to birds via oral 
exposure. Subacute dietary toxicity studies conducted on mallard duck and bobwhite quail 
suggest that flumioxazin is also practically non-toxic, with LC50s of > 5620 mg/kg for the 
technical grade active ingredient. An avian reproduction study on bobwhite quail indicated that 
there were no significant treatment related effects. The NOAEC and the LOAEC were 500 and 
>500 mg/kg, respectively. Also, an avian reproduction study using mallard ducks indicated that 
significant reductions in the number of viable embryos and live 3-week embryos were evident at 
the highest concentration (500 mg/L). The (NOAEC and the LOAEC were 250 and 500 mg/kg, 
respectively. 
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Non-target Insects: Flumioxazin is practically non-acutely toxic to bees (LD50 > 105 µg/bee). 
 
 
3.1.3  Toxicity to  to Plants 
 
Flumioxazin belongs to a class of herbicides known to have a photo-toxic mode of action in 
plants. Plant toxicity data are summarized below.  
 
A seedling emergence study with terrestrial plants indicated that the most sensitive monocot and 
most sensitive parameter were ryegrass and dry weight, respectively. The EC50 and NOAEL for 
the study was 0.0037 lb ai/A and 0.003 lb ai/A, respectively. The most sensitive dicot and most 
sensitive parameter was lettuce and also dry weight, respectively. The EC25 and NOAEL for the 
study was 0.0008 lb ai/A and 0.0004 lb ai/A, respectively.  
 
A vegetative vigor study with terrestrial plants indicated that the most sensitive monocot and most 
sensitive parameter were oat and dry weight, respectively. The EC50 and NOAEL for the study 
was 0.0071 lb ai/A and 0.006 lb ai/A, respectively. The most sensitive dicot and most sensitive 
parameter were cucumber and phytotoxicity, respectively. The EC25 and NOAEL for the study 
were 0.00008 lb ai/A and 0.00005 lb ai/A, respectively.  
 
Toxicity to the freshwater green alga (Selenastrum capricornutum) was characterized with an 
EC50 of 1.02 µg/L and a NOAEC of 0.79 µg/L. Toxicity to the freshwater diatom (Navicula 
pelliculosa) was characterized by a EC50 of 1.4 µg/L and a NOAEC of 0.041 µg/L. Toxicity to the 
marine diatom (Skeletonema costatum) was characterized by an EC50 of 19.2 µg/L and a NOAEC 
of 1.9 µg/L. The 5-day toxicity to the freshwater blue-green alga (Anabaena flos aquae) was 
characterized by an EC50 of 0.83 µg/L and a NOAEC of 0.022 µg/L.  These toxicity values 
indicate that flumioxazin is from moderately to very highly toxic to marine and freshwater algae.  
 
The toxicity to the aquatic vascular plant duckweed (Lemna gibba) was characterized by an EC50 
of 0.49 µg/L and a NOAEC of 0.22 µg/L. 
 
These data indicate that flumioxazin has a high, non-selective, acute toxicity to all plants from 
terrestrial to planktonic unicellular to vascular aquatic plants. 
 
 
3.1.4  Degradate Toxicity 
 
The major flumioxazin degradates of concern are 482-HA, APF and THPA. Few data are 
available to assess the potential toxicity of these compounds. Therefore EPA conservatively 
assumed that they are equally as toxic as the parent compound. The aquatic exposure to 
flumioxazin was addressed through a total residues approach that includes concentrations of the 
parent, 482-HA, APF, and THPA. However, due to limitations in terrestrial models in addition to 
the mobility and relative lack of persistence of the degradates, the parent flumioxazin was 
assessed in the terrestrial risk assessment. 
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MDAR staff estimated the aquatic toxicity of degradates using the ECOSAR program (Appendix 
1). The results indicate that the degradates have generally lower toxicity to aquatic organisms 
than flumioxazin (10 – 1310 lower, mean 254), except the APF degradate whose predicted 
toxicity for invertebrates (Daphnia) is similar to that of flumioxazin.  
 
 
 3.2  Exposure Assessment for Direct Applications to Water 
 
3.2.1  Aquatic Exposure Assessment 
 
The aquatic exposure assessment by USEPA was based on the maximum application rate with a 
target concentration of 400 µg/L flumioxazin. The concentration of the major degradates was 
estimated based on the hydrolysis degradation profile of flumioxazin. This assessment was 
similar to the drinking water assessment described in Section 2.5. The estimated surface water 
concentrations are listed in Table 3.2. 
 
MDAR staff noted that the 21-day and 60-day average values for flumioxazin reported by 
USEPA were not averages but calculated concentrations on day 21 and day 60. The true average 
values were calculated by MDAR staff and were found to be 38 µg/L and 39 µg/L, respectively.  
 
 
Table 3.2. Estimated Environmental Concentrations (EECs) for flumioxazin and its major 
degradates in surface water resulting from aquatic herbicide application (3 applications with 400 
ug/L at  28-day intervals (USEPA, 2010A). The EEC values for the degradates were based on the 
hydrolysis degradation profile. 
Compound Peak (µg/L) 21-day “average” 1) (µg/L) 60-day “average” 1) (µg/L) 
Flumioxazin 400 0.0002 (38)  25 (39) 
482-HA 21.6 21.6 21.6 
APF 110.1 110.1 110.1 
THPA 88.9 88.9 88.9 
1
 MDAR staff noted that these values were not averages but calculated concentrations for day 21 and day 
60, respectively. The average values in parentheses were determined by MDAR staff. 
 
 
To supplement the exposure assessment by USEPA described above, MDAR staff generated 
EECs of flumioxazin and its major degradates using simulations with the AQUATOX model. 
The degradation of flumioxazin and degradates was based on the half-lives observed in an 
aquatic field study in Iowa (see Section 1.4). The application scenario assumed a single 
application at 200 µg/L. The half-lives used for model input were 1 day for flumioxazin, 4.9 days 
for 482-HA and 10.5 days for APF. Since THPA was not monitored in the Iowa field study, it 
was assumed to have the same half-life as APF. This seems a reasonable assumption based on 
the hydrolysis degradation pattern that showed similar levels of these two degradates. Further 
details on the simulations can be found in Appendix 2. The AQUATOX model-generated 
concentration profiles are shown in Fig. 3.1. The concentration profiles show a rapid decline for 
flumioxazin with concurrent rapid appearance of 482-HA.This degradate, in turn, rapidly 
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declines and results in the simulated formation of APF and THPA. The AQUATOX estimated 
values for peak level, and 21-d and 60-d averages are listed in Table 3.3.  
 
Figure 3.1 Aquatic concentrations of flumioxazin and its major degradates simulated by the AQUATOX model. 
The concentration profiles are the result of a single application at day 10 (May 10th). The degradation rates were 
based on half-lives observed in an aquatic field study in Iowa  
 
Compared to the field data from an Iowa pond (Section 1.4) and the degradation profiles 
observed by Shibata et al. (2011), the model results show a somewhat more persistent 
flumioxazin and a slightly delayed appearance of the degradate 482-HA. The model also 
simulates a more prolonged presence in the water compared to the field and lab study results. 
The simulated dissipation profile for THPA is similar to the profiles observed in the field study 
and laboratory study by Shibata (2011). In the simulation, APF was assumed to be formed as a 
result from 482-HA degradation, but this degradate did not appear prominently in the Iowa field 
study or the laboratory study on aquatic fate by Shibata et al. (2011).  
 
 
Table 3.3. Estimated Environmental Concentrations (EECs) for peak, 21-day and 60-day averages 
of Flumioxazin and major degradates based on AQUATOX simulated concentration in surface 
water. See Appendix 2 for more details on model simulations. Initially applied concentration of 
flumioxazin was 200 µg/L.  
Compound Peak (µg/L) (day) 21-day average (µg/L) 60-day average (µg/L) 
Flumioxazin 200 (day 1) 15.7 5.6 
482-HA 104 (day 4) 37.5 13.7 
APF 37 (day 13) 21.7 11.5 
THPA 37 (day 13) 21.7 11.5 
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Considering the exposure data review above, it is clear that overall the EPA assessment data 
represent a high-end exposure scenario. The peak value for flumioxazin assessed by EPA is the 
theoretical maximum concentration that may occur immediately following the application before 
any degradation would have taken place. In the Iowa field study, a peak concentration of 233 
µg/L was observed two hours following the application, which was calculated to be 58% of the 
theoretical maximum of 400 µg/L. While the model-simulated peak concentration and field-
measured peak concentration do not account for the initial brief exposure to maximum 
concentration, these results indicate that the exposure to the maximum concentration is very 
short. Uptake by target vegetation and degradation of flumioxazin results in a rapid decline of 
flumioxazin concentrations.   
 
In contrast, the peak EEC for the degradate 482-HA used by EPA is much lower than the EEC 
based on AQUATOX simulation. The peak EEC for APF and THPA are also smaller than the 
EPA-assessed values, which is also attributable to the lower applied concentration. Overall, the 
values used by EPA for risk assessment are conservative. The AQUATOX simulated scenario 
represents a scenario that is used by vegetation management professionals. Comparison with the 
data from the Iowa field study and the laboratory study by Shibata et al. (2011) indicate that 
flumioxazin and its degradates are generally less persistent than indicated by exposure data from 
EPA or the AQUATOX simulation.  
 
Partitioning between the water and sediment phases also affects the aquatic fate. The Iowa field 
study analyzed sediment which indicated that partitioning into sediment of flumioxazin and its 
major degradates did take place. Shibata et al. (2011) suggest that the presence of sediment 
reduced fractions of flumioxazin and degradates in the water phase and thereby reduced the 
potential for hydrolysis and photolysis. At the same time, these compounds are increasingly 
subjected to microbial degradation. Thereby, the sediment phase appeared to act as a sink for 
flumioxazin and degradates. The Shibata study points out that bound residue (detected by bound 
radioactivity) likely includes the fragments of advanced degradation to minor degradates. As the 
data indicate, the parent and major degradates were not present at significant levels.  
 
 
3.2.2 Terrestrial Exposure Assessment 
 
USEPA (2010A) assessed the risk to avian and terrestrial species based on a worst-case exposure 
scenario assuming that the entire application (0.383 lbs ai/A) is applied to the shoreline multiple 
times during the season. Exposure to birds and mammalian species was based on residues on 
various food items.  This scenario would be highly conservative since the maximum surface 
application is not expected to be applied to any non-aquatic area. The maximum EEC on short 
grass was 206 mg/L, 116 mg/L on tall grass, 95 mg/L on broadleaf plants and insects, and 13 
mg/L on seeds, fruits, and large insects.  
 
Terrestrial plants inhabiting dry and semi-aquatic areas may be exposed to pesticides from 
runoff, spray drift or volatilization. Semi-aquatic areas are those low-lying wet areas that may be 
dry at certain times of the year. EFED's runoff scenario is: (1) based on a pesticide's water 
solubility and the amount of pesticide present on the soil surface and its top one inch, (2) 
characterized as "sheet runoff" (one treated acre to an adjacent acre) for dry areas, (3) 
  
MDAR/MassDEP 24 June 2013 
 
characterized as "channelized runoff" (10 treated acres to a distant low-lying acre) for semi-
aquatic areas, and (4) based on % runoff values of 0.01, 0.02, and 0.05 for water solubility of 
<10 mg/L, 10-100 mg/L, and >100 mg/L, respectively. Spray drift exposure from ground 
application is assumed to be 1% of the application rate. Based on a single application of 0.38 lbs 
ai per acre, the total loading to an adjacent dry area was estimated to be 0.0077-0.0214 lbs 
ai/acre, 0.0421 lbs ai/acre to a semi-aquatic area, and 0.0038-0.0192 lbs ai/acre through spray 
drift.  
 
Some ecologically important and common semi-aquatic terrestrial species such as muskrats and 
beaver may be exposed to herbicides applied to aquatic habitats through a variety of routes: 
water ingestion, dermal absorption, oral ingestion from preening activity and ingestion of 
contaminated vegetation. The risks to these 2 species from ingestion of water containing 
flumiozaxin and its degradates were assessed for the application scenario described in the human 
drinking water assessment (Section 2.4): a single 200 ug/L application giving peak, 21-day and 
60-d average concentrations of the compounds (Table 3.3).   
 
3.3 Risk Characterization and Risk Description 
 
Ecological risk characterization integrates the exposure and ecotoxicity data to evaluate the 
likelihood of adverse ecological effects. EPA typically uses a deterministic approach to evaluate 
the likelihood of adverse ecological effects to non-target species. In this approach, risk quotients 
(RQs) are calculated by dividing EECs by ecotoxicity values for non-target species, both acute 
and chronic. RQs are then compared to established levels of concern (LOCs) (Appendix 3). 
These LOCs are criteria used by EPA to indicate potential risk to non-target organisms and the 
need to consider regulatory action or refined risk assessment. Terrestrial risk assessments were 
based on exposure to flumioxazin. Aquatic risk assessments were based on exposure to residues 
of flumioxazin and degradates 482-HA, APF and THPA. 
 
3.3.1  Aquatic Animals  
The individual compound RQs determined by EFED for freshwater fish and invertebrate species 
were in the range of 0.04 to 0.17 for acute risk and 2.8 to 14.28 for chronic risk (Table 3.4 and 
Appendix 3). The LOC for acute high risk is 0.5, 0.05 for endangered species, and 1 for chronic 
risk. Acute LOCs were exceeded for endangered freshwater fish and chronic LOCs were 
exceeded for all freshwater fish. The acute LOCs were exceeded for endangered invertebrates 
and chronic risk LOCs for flumioxazin, APF and THPA degradates.   
 
Table 3.4 Summary of RQs for Aquatic Animals Determined by EPA-EFED. Shading indicates exceedance of 
LOC.   
 Fish Invertebrates 
Compound Acute RQ Chronic RQ Acute RQ Chronic RQ 
Flumioxazin 0.170 1.500 0.070 1.350 
482-HA 0.009 2.800 0.004 0.770 
APF 0.047 14.280 0.020 3.930 
THPA 0.038 11.540 0.010 3.170 
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The RQ values indicate that acute risk to endangered species is of concern, but chronic risk is of 
most concern. USEPA addressed the indicated risks by pointing out that the risks were calculated 
by using high-end EECs associated with the maximum application rates and degradation via 
hydrolysis. Real exposure levels are expected to be lower as is indicated by the results from 
monitoring concentrations in field studies. The highest RQs were determined for APF. As 
pointed out with the exposure assessment in Section 3.2.1, APF is expected not to occur as a 
prominent degradate based on data from field and laboratory aquatic fate studies. The next 
highest RQs were determined for THPA which is expected to occur based on field studies, but 
typically not at the levels as used in the USEPA risk assessment. Considering the conservative 
assumptions in the exposure assessments, EPA expected that real risks to aquatic organisms are 
lower than indicated by the RQ values discussed above.  
 
Based on the indicated risks in EPA’s risk assessment, MDAR performed a refined aquatic life 
risk assessment for the review presented here. Additional risk quotient calculations were 
performed for the exposure data from the field study in a pond in Iowa (Section 1.4) and for the 
refined exposure data from AQUATOX modeling (Table 3.3). The results of these calculations 
can be found in Appendix 4. Compared to EPA assessment, RQ values are generally lower, but 
certain LOCs are still exceeded.  
 
EPA did not assess the combined effects of flumioxazin and its degradates. For the peak 
exposure data, a simple summation of all exposures is not realistic since the peak levels of the 
individual compounds do not occur at the same time (see also Table 3.3). For acute exposures, it 
is realistic to consider the peak concentrations of flumioxazin and its primary degradate 482-HA. 
For the 21-d and 60-d averaged exposure data, it is realistic to add the concentrations of 
flumioxazin and the three degradates to estimate the total exposure, although these longer term 
exposures are dominated by the occurrence of the APF and THPA degradates.  Based on the 
assumption of equal toxicity, the RQ was calculated based on the total exposures. The results of 
this analysis are included in Table 1 and 2 in Appendix 4. Comparison of RQ with LOCs 
indicates acute risk for categories of endangered species and acute restricted use. However, the 
restricted use category does not apply to flumioxazin. The chronic risk LOC is exceeded for the 
EPA and DAR assessments, the assessment for the Iowa monitoring study data did not exceed 
the chronic LOC, but this is likely due to the lack of data for THPA exposure.  
 
 
The risk characterization described above was based on the assumption of equal toxicity for 
flumioxazin and degradates. The risk assessment was further refined by use of ECOSAR-
estimated toxicity endpoints for the degradates using the ECOSAR program. Details on this 
analysis are provided in Appendix 4. The results indicate that the degradates have generally a 
lower toxicity to aquatic organisms than flumioxazin, except the APF degradate for which the 
endpoints for invertebrates approach or are lower than the value for the parent.  
 
The risk characterization was refined by adjusting the assumed toxicity endpoint values for the 
degradates. The ECOSAR-predicted toxicity endpoints were not directly used in the RQ 
calculation. Since the predicted toxicity values for flumioxazin were higher than the study data, a 
more conservative approach was used. The degradate endpoints were calculated by multiplying 
the endpoint point value for flumioxazin (study data) by the ratio of predicted degradate 
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endpoint/predicted endpoint for flumioxazin. RQ values were calculated for the AQUATOX-
generated exposure data and the results can be found in Appendix 4. For the individual 
compounds acute LOC of 0.05 is only exceeded for flumioxazin exposure to endangered fish, 
and chronic LOCs of 1 is only  exceeded with 21-d RQ for fish,  the 60-d RQ does not exceed 
the chronic LOC. EPA uses 56 or 60-day RQ for chronic risk to fish3. 
 
The risk assessment was further refined by considering the concentration addition approach to 
estimate toxic unit (TU) summation for combined effect. Details on this assessment are described 
in Table 3 and 4 in Appendix 4. If one applies the same LOC thresholds for TU summation 
values, the LOCs for acute risk to endangered fish and 21-d TU for chronic effects to fish are 
exceeded. For invertebrates, the 21-d TU exceeds the LOC for chronic effects.  
 
EPA did not assess the risks to estuarine/marine fish or invertebrates because the product may 
not be used in those areas. MDAR included a risk assessment for estuarine/marine organisms 
(Table 6 and 7 in Appendix 4). These data can be used as a reference point for evaluation of risks 
in situations where treated freshwater may enter into estuarine/coastal waters. Acute toxicity data 
for flumioxazin indicate that it is slightly less toxic to estuarine/marine organisms compared to 
freshwater organisms (Table 3.1). There are no chronic toxicity data available for 
estuarine/marine fish and therefore freshwater chronic toxicity data were used for risk 
characterization. Flumioxazin is highly toxic to marine invertebrates. RQs based on EECs in 
treated freshwater show LOC exceedances for 21-d chronic RQ for fish, and acute and chronic 
RQs for invertebrates from exposure to flumioxazin and APF degradate. The extent of dilution 
that would occur is an important factor to consider with an assessment of the potential for risk to 
estuarine/marine organisms in situations where treated freshwater mixes with saltwater . The 
length of time after herbicide treatment until mixing takes place with salt water is an important 
factor; flumioxazin dissipates rapidly and its levels decreases rapidly.  Exposure levels used in 
the risk assessment of APF were based on modeling, but field studies have indicated that this 
degradate does not occur in significant concentrations.  
 
As fish are used as a surrogate for aquatic-phase amphibians when aquatic-phase amphibian 
toxicity data are not available, the risk description of fish above also applies to aquatic-phase 
amphibians. The risk assessments do not specifically address benthic organisms.  
 
  
3.3.2  Terrestrial Organisms 
 
The RQs for birds (Appendix 3) are all below the LOCs for acute and chronic risks. These results 
indicate that no avian acute or chronic levels of concern are exceeded at registered maximum 
application rates.  
 
USEPA’s (2010A) discussion of acute risk to mammals states that the results suggest that 
mammalian acute levels of concern are not exceeded even under the highest multiple application 
                                                 
3
 Technical Overview of Ecological Risk Assessment Risk Characterization: EPA Office of Pesticide Programs; 
Information available at: http://www.epa.gov/oppefed1/ecorisk_ders/toera_risk.htm  
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rates. Flumioxazin is practically non-toxic to mammals (Section 3.1). Actual RQ values were not 
presented in the risk assessment document. The residues expected on mammalian food items 
after aquatic applications of flumioxazin products are based on the highest residue concentrations 
immediately after application. Furthermore, the exposure scenario would be highly conservative 
since the maximum surface application is not expected to be applied to any non-aquatic area, 
thus no risk is assumed.  
 
The chronic LOC of 1.0 was slightly exceeded with RQs of 1.16 to 2.06 for small mammals 
eating short and tall grass in the multiple application of flumioxazin scenario. However, this 
exposure scenario was highly conservative since the product is to be used specifically on aquatic 
sites only. The exposure scenario used was a direct application to the shoreline.  
 
For this report, we determined the risks from direct water ingestion of flumioxazin-treated waters 
by beavers and muskrats (see Appendix 4).  RQ values were calculated as total daily ingested 
doses of flumioxazin and the degradates 482-HA and APF divided by the calculated duration-
specific oral reference doses for those 2 species respectively.  Exposures and risks from other 
routes were not quantitatively evaluated.  Both acute and chronic ingestion risks for beavers and 
muskrats (0.02 – 0.05) were well below the LOC of 1. We do not believe that exposures from 
inhalation or dermal absorption could approach levels that would result in the total risks to these 
animals approaching the LOC (see discussion in Appendix 4). USEPA’s analysis of 
contaminated vegetation ingestion risks noted above concluded no risk from that exposure route. 
 
Currently, EFED does not assess risk of aquatic herbicides to non-target insects. Results of 
acceptable studies are used for recommending appropriate label precautions. As flumioxazin is 
practically non-toxic to honeybees, low risk is assumed. 
 
3.3.3  Risk to Non-Target Plants 
 
The maximum concentration in water (0.400 mg/L) and most sensitive endpoint (EC50 of 0.0005 
mg/L for duckweed) were used to calculate the aquatic plant RQ. The RQ value of 800 exceeds 
the LOC of 1 and indicates that effects to aquatic plants from the application of flumioxazin to 
aquatic areas are likely. This is to be expected from the application of an herbicide to control 
targeted aquatic plants. 
  
Endangered and non-endangered non-target plant species levels of concern are exceeded at 
maximum application rates. RQ values (Appendix 3) indicate that for single broadcast 
applications of flumioxazin, non-endangered non-target terrestrial and semi-aquatic plant species 
levels of concern are exceeded at maximum application rates (RQs ranged from 0.54 to 239.4); 
endangered species RQs ranged from 0.64 to 383 for single applications. A single maximum 
application rate of 0.38 lbs ai/acre is 54.7 to 7,660 times higher than the least (0.007 lbs ai/A) 
and most (0.00005 lbs ai/A) toxic NOAEL in submitted terrestrial plant studies, respectively. 
Since flumioxazin may exhibit phototoxicity and phytotoxicity, and RQs exceed LOCs, 
endangered and non-target terrestrial plant species are potentially at risk. This scenario is likely 
conservative since the maximum surface application is not expected to be applied to any non-
aquatic areas where terrestrial plants may be exposed.  
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EPA does not specifically address the risk to planktonic unicellular algae. Based on the acute 
toxicity information for green algae (EC50 of 1.02 µg/L) and an acute exposure of 200-400 µg/L, 
the RQ would be approximately in the range of 200-400. This indicates that effects to green 
algae are likely from aquatic applications of flumioxazin.   
 
A study by Umphres et al. (2012) provides  information on effects of flumioxazin applications, 
including effects of flumioxazin on phytoplankton and zooplankton in a treated water body.  The 
study evaluated the efficacy of flumioxazin for treatment of harmful algae blooms known as 
golden algae (Prymnesium parvum). In the US, golden algae occur mostly in brackish waters of 
the southern states and are of concern for causing extensive fish kills. Flumioxazin was applied 
to natural plankton communities during in-lake experiments using 20-L carboys filled with lake 
water and covered with 30% shade cloth to simulate natural in-situ light, temperature and 
turbulence conditions. The results from the experiment conducted during the pre-bloom period 
using application rates of 0-200 µg/L showed significant decreases in P. parvum densities, and 
total phytoplankton biomass. Adult copepod abundance slightly decreased compared to initial 
level at the highest rate of 200 µg/L.  Adult copepod, copepod nauplii and rotifer densities all 
decreased in all flumioxazin concentrations. On the other hand, the cladocera abundance did not 
change significantly across doses levels.  of inorganic nutrients showed opposite trends from 
phytoplankton, where declines in nitrogen and phosphorus were less with addition of 
flumioxazin.  Effects from post-bloom treatment with flumioxazin were not as strong. P. varvum 
densities and total phytoplankton did not show significant differences with flumioxazin 
concentration. Nutrients showed a general increasing trend with flumioxazin concentration. 
Adult copepods increased compared to initial cove conditions, but less with flumioxazin 
concentration increase. Copepods nauplii decreased with higher flumioxazin concentrations. 
Cladocera and rotifers showed no trends with flumioxazin concentration increase. The absence 
of significant effects of flumioxazin treated during the post-bloom experiment was attributed to 
the limited light penetration due to higher turbidity which inhibits the light-sensitive mode of 
action of flumioxazin. The authors concluded that additional research is needed to better 
determine optimal application  rates, timing, and factors such as cell density, light and pH. 
Ecosystem responses such as phytoplankton composition shifts also require further investigation.  
  
3.3.4  Threatened and Endangered Species Concerns 
 
In accordance with the Endangered Species Act, USEPA addressed the concerns for effects to 
federally threatened and endangered species (listed species) (USEPA, 2010A). For terrestrial and 
aquatic plant species as well as for freshwater fish and invertebrates evaluated in EPA’s risk 
assessment, RQs exceeded the LOCs for the exposure scenarios considered (surface and 
subsurface applications to freshwater). Below is a summary of how USEPA plans to address the 
concerns during registration review. 
 
The assessment of risk to listed species includes the identification of an action area, which for 
screening-level purposes, is conservatively assumed to be co-located with the pesticide treatment 
area.  
 
An indirect effects analysis is done to assess the potential to exert indirect effects upon the listed 
organisms by, for example, perturbing forage or prey availability, altering the extent of nesting 
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habitat, and creating gaps in the food chain. In conducting a screen for indirect effects, direct 
effect LOCs for each taxonomic group are used to make inferences concerning the potential for 
indirect effects upon listed species that rely upon non-endangered organisms in these taxonomic 
groups as resources critical to their life cycle. 
 
Because screening-level acute RQs exceeded the endangered species acute LOCs, USEPA uses 
the dose response relationship from the toxicity study used for calculating the RQ to estimate the 
probability of acute effects associated with an exposure equivalent to the EEC. This information 
serves as a guide to establish the need for and extent of additional analysis that may be 
performed.  
 
Screening-level RQs for birds and mammals that feed on short grass, tall grass, broadleaf plants 
and small insects, and fruits, pods, and large insects that exceed the LOC may indicate a 
potential concern for indirect effects. USEPA considers this to be indicative of a potential for 
adverse effects to those listed species that rely either on a specific plant species (plant species 
obligate) or multiple plant species (plant dependent) for some important aspect of their life cycle. 
Alterations of habitats can affect the reproductive capacity of some terrestrial and aquatic 
animals. Due to the fact that terrestrial and aquatic plant RQs exceeded the endangered and non-
endangered LOCs, all species may be affected due to indirect effects. 
 
The screening-level risk assessment has identified potential concerns for indirect effects on listed 
species. In light of the potential for indirect effects, the next step for USEPA, and U.S. Fish and 
Wildlife Service and NOAA Fisheries Service (together referred to as the Services) is to identify 
which listed species and critical habitat are potentially implicated. At the time of the risk 
assessment, the information reviewed by USEPA did not permit a definitive identification of 
species that are potentially impacted indirectly or critical habitats that are potentially impacted 
directly by the use of the pesticide. USEPA and the Service(s) are working together to conduct 
the necessary analysis. 
 
It should be noted that the potential impact to and protection of state-listed and endangered 
species in Massachusetts is addressed during the process of application for and review of aquatic 
herbicide applications licenses.   
 
This approach is also used by the Department of Ecology in Washington State (WA) (Hamel, 
2012). Risk mitigation of potential impacts to threatened and endangered species is done by 
requiring applicators to comply with timing windows. These windows either do not allow 
herbicide treatment or allow treatment at times when the herbicide will not affect the priority 
species or its food and habitat.  
 
3.3.5  Uncertainties and Data Gaps  
 
The uncertainties identified in the risk assessment for aquatic use of flumioxazin (USEPA, 
2010A) are related to fate and toxicity of  the degradates. The fate of the major degradates 
detected in the hydrolysis and the aqueous photolysis as well as those unidentified residues 
reported in the anaerobic aquatic metabolism study in the natural environments remains 
unknown.  
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At the time of the completion of the aquatic risk assessment (USEPA, 2010A), EFED did not 
require any additional fate data. In addition, the toxicities of the major degradates are unknown. 
EFED did not require toxicity studies at that time due to risk quotients indicating low concern. 
As pointed out in the review presented here, the RQs determined by USEPA can be considered 
to be of concern (Section 4.3). The refined risk assessment resulted in lower RQ values and 
fewer exceedances of LOCs.  
 
USEPA (2010A) recommended that phototoxicity studies should be conducted on herbicides 
with the mode of action associated with LDPHs to determine if animals exposed to these LDPHs 
and intense light (similar to sunlight) show increased toxicity relative to controls exposed to 
LDPHs and low intensity light. The results of these studies will help to determine if animals that 
are exposed to sunlight in LDPH use areas are at higher risk than guideline toxicity studies 
suggest. USEPA expects that these data will become available for the registration review risk 
assessment of flumioxazin (USEPA, 2011A). At the time of the review presented here, these data 
were not available.  Based on these data gaps, it is possible that risks to human health and aquatic 
life have been underestimated. 
 
With the initiation of the registration review of flumioxazin, EFED performed a preliminary 
identification of data gaps (USEPA, 2011B). The data requirements for environmental fate of 
flumioxazin were all found to be satisfied. However, data gaps remain in the fate database for 
degradates. Relative to ecological effects, data gaps and uncertainties were identified and are 
described below. These data gaps will be addressed with the registration review.  Missing 
information regarding anaerobic metabolism and information on benthic organism toxicity were 
not identified as data gaps by EPA. 
 
Freshwater Invertebrate Acute LC50: A study was submitted that examined the toxic effects of 
flumioxazin on freshwater invertebrates. However, the study showed high levels of precipitate in 
the solutions. These precipitates likely confounded the effects of the chemical itself. A new study 
is needed to address the uncertainty related to an accurate assessment of the toxicity of 
flumioxazin to freshwater free-swimming invertebrates.  
 
No toxicity studies are available on flumioxazin effects on freshwater mussels.  Massachusetts 
has a number of state-listed freshwater mussels and in general freshwater mussels are among the 
most endangered organisms in North America (Smith, n.d.) 
 
Freshwater Fish Early Life-Stage: An additional study needs to address the potential UV light-
enhanced toxicity for freshwater fish based on the LDPH nature of flumioxazin.  
 
Estuarine/Marine Fish Early Life-Stage: It was determined that an early life-stage study is 
conditionally required. This determination was based on the condition of an EEC in water is ≥ 
0.01 of the acute EC50 or LC50. The 60 day average flumioxazin parent concentration was 
determined to be 25 µg/L, which is less than 0.01 of the acute LC50 of > 4.7 mg/L (0.01 * 4.7 
mg/L = 47µg/L). However, the 60 day average concentration for the degradate APF was 110 
µg/L (section 5.2.1.1). No data are available regarding the toxicity of any of the degradates. 
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Without these data, the degradates are assumed to be as toxic as the parent compound, and 
therefore the above condition is met. Considering that flumioxazin is an LDPH and may have 
enhanced toxicity under elevated light conditions, the results of the freshwater fish early life-
stage test that addresses light-enhanced toxicity may be applied to the results of this study as 
appropriate.  
 
Fish Full Life-Cycle: According to the CFR 40 part 158 guidelines, this study is conditionally 
required when “the end-use product is intended to be applied directly to water, or is expected to 
be transported to water from the intended use site, and when any of the following conditions 
apply: 
• If the estimated environmental concentration (EEC) is ≥ 0.1 of the no-observed-effect 
level in the fish early-life stage or invertebrate life cycle test; 
• If studies of other organisms indicate that the reproductive physiology of fish may be 
affected.” 
 
Flumioxazin has aquatic uses that indicate the chemical will be applied directly to freshwater 
systems, which meets the first part of the criteria. The peak EEC for parent flumioxazin based on 
the previous aquatic risk assessment (USEPA, 2010A) is 400 µg/L. The NOAEC in the fish early 
life-stage is 7.7 µg/L and in the invertebrate life-cycle is 28 µg/L. Therefore, 0.1 of the peak EEC 
(0.1*400 µg/L = 40 µg/L) is greater than both of these no effect levels, and therefore the second 
condition is also met. Furthermore, reproductive effects were observed in the freshwater 
invertebrate life-cycle test. A study on the fish full life-cycle is needed to address this remaining 
uncertainty of chronic risk to fish.  
 
Avian Oral LD50: CFR 40 part 158 guidelines require data on one passerine species and either a 
waterfowl or upland game bird species. Data has only been submitted for the Bobwhite quail. 
There is uncertainty as to the sensitivity of passerine species compared to other bird species. 
However, no mortality in any treatment group was reported in both the acute oral and dietary 
toxicity studies for avian species. 
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Appendix 1 
Aquatic Toxicity Estimation of Flumioxazin, and its degradates 
482-HA, APF, and THPA                                                                                                            
using ECOSAR Aquatic Toxicity Prediction Program 
 
In absence of test data, the aquatic toxicity of THPA was estimated using the ECOSAR program.  
The Ecological Structure Activity Relationships (ECOSAR) Class Program is a computerized 
predictive system that estimates aquatic toxicity. The program estimates a chemical's acute 
(short-term) toxicity and chronic (long-term or delayed) toxicity to aquatic organisms such as 
fish, aquatic invertebrates, and aquatic plants by using computerized Structure Activity 
Relationships (SARs).4) 
 
ECOSAR uses structure-activity relationships (SARs) to predict the aquatic toxicity of untested 
chemicals based on their structural similarity to chemicals for which aquatic studies are 
available.  Application of structure activity relationships is a technique routinely used by the U.S. 
EPA Office of Pollution Prevention and Toxics under the New Chemicals Program. The toxicity 
data used to build the SARs are collected from publicly available experimental studies and 
confidential submissions provided to the U.S. EPA New Chemicals Program. The SARs in 
ECOSAR express correlations between a compound's physicochemical properties and its toxicity 
within specific chemical classes.   
 
Through publication of the ECOSAR Model, the U.S. EPA provides public access to the same 
methods the EPA uses for evaluating aquatic toxicity.  Many of the SARs have been validated 
through studies published in the open literature or through validation activities conducted by the 
U.S. EPA is conjunction with other regulatory agencies.   
 
The results from the ECOSAR calculations for Flumioxazin, 482-HA, APF and THPA are 
included at the end of this document.  
 
The predicted toxicity endpoint values as LC50/EC50s are summarized in Table 1. The values 
listed are the lowest predicted values for each compound. Comparison of the results indicates 
that the parent flumioxazin has generally the lowest endpoint values. The endpoint values for the 
degradates are generally higher, except the APF degradate for which the endpoints for Daphnia 
approach or are lower than the value for the parent flumioxazin.  
 
 
 
 
 
                                                 
4
 ECOSAR information available at: Ecological Structure Activity Relationships | New Chemicals Program | 
USEPA 
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Table 1 Summary of ECOSAR predicted toxicity endpoint values  
 Acute Toxicity Endpoints (mg/L) Chronic Toxicity Endpoints (mg/L) 
 
Fish 96-hr 
LC50 
Daphnid 
48-h LC50 
Algae 96-h 
EC50 Fish Daphnid  Algae 
Flumioxazin1 16.7 11.4 0.55 0.10 0.15 0.59 
482-HA2 1262 1022 19 32 88 6.2 
APF3 395 5.5 16 3.1 0.16 11 
THPA4 1259 712 341 131 83 131 
1
 Lowest predicted values for ECOSAR class of amides 
2
 Lowest predicted values for ECOSAR class of acrylamides-acid (fish, daphnid); class of 
amides-acid for green algae 
3
 Lowest predicted values for ECOSAR class of anilines 
4
 Lowest predicted values for ECOSAR class of neutral organic acids 
 
 
Table 2 Ratios of Degradate endpoint (LC50/EC50)/Flumioxazin endpoint for values listed in 
Table 1. 
 Ratio Degradate/Flumioxazin (acute) Ratio Degradate/Flumioxazin (chronic) 
 
Fish 96-hr 
LC50 
Daphnid 
48-h LC50 
 Algae 96-
h EC50 Fish Daphnid  Algae 
Flumioxazin 1 1 1 1 1 1 
482-HA 75.6 89.6 34.5 320.0 586.7 10.5 
APF 23.7 0.5 29.1 31.0 1.1 18.6 
THPA 75.4 62.5 620.0 1310.0 553.3 222.0 
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RESULTS FOR Flumioxazin: 
 
 
SMILES : C#CCN1c2cc(c(cc2OCC1(=O))F)N3C(=O)C4=C(C3(=O))CCCC4 
CHEM   :  
CAS Num: 635-08-5 
ChemID1:  
ChemID2:  
ChemID3:  
MOL FOR: C19 H15 F1 N2 O4  
MOL WT : 354.34 
Log Kow: 2.55  (User entered) 
Melt Pt: 202.00 deg C 
Wat Sol: 1.8 mg/L  (measured) 
 
ECOSAR v1.00a Class(es) Found 
------------------------------ 
Imides 
Amides  
                                                                    Predicted 
ECOSAR Class                 Organism            Duration  End Pt   mg/L (ppm) 
===========================  ==================  ========  ======   ========== 
Imides                     : Fish                96-hr     LC50       38.448 * 
Imides                     : Daphnid             48-hr     LC50       44.288 * 
Imides                     : Green Algae         96-hr     EC50        3.390 * 
Imides                     : Fish                          ChV         3.751 *! 
Imides                     : Daphnid                       ChV         3.871 *! 
Imides                     : Green Algae                   ChV         1.747 
 
Amides                     : Fish                96-hr     LC50       16.758 * 
Amides                     : Daphnid             48-hr     LC50       11.414 * 
Amides                     : Green Algae         96-hr     EC50        0.547 
Amides                     : Fish                          ChV         0.099 
Amides                     : Daphnid                       ChV         0.151 ! 
Amides                     : Green Algae                   ChV         0.592 
 
===========================  ==================  ========  ======   ========== 
Neutral Organic SAR        : Fish                96-hr     LC50       93.478 * 
(Baseline Toxicity)        : Daphnid             48-hr     LC50       57.648 * 
                           : Green Algae         96-hr     EC50       31.146 * 
                           : Fish                          ChV         8.767 * 
                           : Daphnid                       ChV         5.868 * 
                           : Green Algae                   ChV        12.463 * 
 
 Note:  * = asterisk designates: Chemical may not be soluble 
        enough to measure this predicted effect. 
  
 Note:  ! = exclamation designates: The toxicity value was determined from 
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     a predicted SAR using established acute-to-chronic ratios and ECOSAR 
     regression techniques which are documented in the supporting Technical 
     Reference Manual. When possible, this toxicity value should be 
     considered in a weight of evidence approach. 
  
Imides: 
------ 
  For Fish and Daphnid Acute Toxicity Values: If the log Kow of the chemical 
is greater than 5.0, or if the compound is solid and the LC50 exceeds the 
water solubility by 10X, no effects at saturation are predicted for these 
endpoints. 
  
  For Green Algae Acute Toxicity Values: If the log Kow of the chemical is 
greater than 6.4, or if the compound is solid and the EC50 exceeds the water 
solubility by 10X, no effects at saturation are predicted for these endpoints. 
  
  For All Chronic Toxicity Values: If the log Kow of the chemical is greater 
than 8.0, or if the compound is solid and the ChV exceeds the water solubility 
by 10X, no effects at saturation are predicted for these endpoints. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: 5.0 (LC50) 
Maximum LogKow: 6.4 (EC50) 
Maximum LogKow: 8.0 (ChV) 
Maximum Mol Wt: 1000 
  
Amides : 
------- 
No limitations known at this time. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: >8.5 (LC50) 
Maximum LogKow: >8.0 (EC50,ChV) 
Maximum Mol Wt: 1000 
  
Baseline Toxicity SAR Limitations: 
--------------------------------- 
Maximum LogKow: 5.0 (Fish 96-hr LC50; Daphnid LC50) 
Maximum LogKow: 6.4 (Green Algae EC50) 
Maximum LogKow: 8.0 (ChV) 
Maximum Mol Wt: 1000 
  
 
 
------------------------------------------------------------------------------ 
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RESULTS FOR DEGRADATE 482-HA: 
 
SMILES : C#CCN1c2cc(c(cc2OCC1(=O))F)NC(=O)C3=CCCCC3(C(=O)O) 
CHEM   :  
CAS Num:  
ChemID1:  
ChemID2:  
ChemID3:  
MOL FOR: C19 H17 F1 N2 O5  
MOL WT : 372.36 
Log Kow: 0.72  (KowWin estimate) 
Melt Pt:   
Wat Sol: 1092 mg/L  (WskowWin estimate) 
 
ECOSAR v1.00a Class(es) Found 
------------------------------ 
Acrylamides-acid 
Amides -acid 
                                                                    Predicted 
ECOSAR Class                 Organism            Duration  End Pt   mg/L (ppm) 
===========================  ==================  ========  ======   ========== 
--> Acid moeity found: Predicted values multiplied by 10 
 
Acrylamides-acid           : Fish                96-hr     LC50     1262.728 * 
Acrylamides-acid           : Daphnid             48-hr     LC50     1022.147 
Acrylamides-acid           : Fish                          ChV        31.760 
Acrylamides-acid           : Daphnid                       ChV        88.081 ! 
Acrylamides-acid           : Fish  (SW)          96-hr     LC50     1119.478 * 
Acrylamides-acid           : Mysid Shrimp (SW)   96-hr     LC50      472.667 
Acrylamides-acid           : Fish  (SW)                    ChV        62.509 ! 
Acrylamides-acid           : Mysid Shrimp (SW)             ChV         0.358 
 
Amides -acid               : Fish                96-hr     LC50     4901.646 * 
Amides -acid               : Daphnid             48-hr     LC50     1776.507 * 
Amides -acid               : Green Algae         96-hr     EC50       18.556 
Amides -acid               : Fish                          ChV        28.976 
Amides -acid               : Daphnid                       ChV        23.435 ! 
Amides -acid               : Green Algae                   ChV         6.221 
 
===========================  ==================  ========  ======   ========== 
Neutral Organic SAR        : Fish                96-hr     LC50     3450.105 * 
(Baseline Toxicity)        : Daphnid             48-hr     LC50     1706.145 * 
                           : Green Algae         96-hr     EC50      435.656 
                           : Fish                          ChV       336.889 
                           : Daphnid                       ChV       125.742 
                           : Green Algae                   ChV       124.887 
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 Note:  * = asterisk designates: Chemical may not be soluble 
        enough to measure this predicted effect. 
  
 Note:  ! = exclamation designates: The toxicity value was determined from 
     a predicted SAR using established acute-to-chronic ratios and ECOSAR 
     regression techniques which are documented in the supporting Technical 
     Reference Manual. When possible, this toxicity value should be 
     considered in a weight of evidence approach. 
  
Acrylamides: 
----------- 
  For Fish and Daphnid Acute Toxicity Values: If the log Kow of the chemical 
is greater than 5.0, or if the compound is solid and the LC50 exceeds the 
water solubility by 10X, no effects at saturation are predicted for these 
endpoints. 
  
  For Green Algae Acute Toxicity Values: If the log Kow of the chemical is 
greater than 6.4, or if the compound is solid and the EC50 exceeds the water 
solubility by 10X, no effects at saturation are predicted for these endpoints. 
  
  For All Chronic Toxicity Values: If the log Kow of the chemical is greater 
than 8.0, or if the compound is solid and the ChV exceeds the water solubility 
by 10X, no effects at saturation are predicted for these endpoints. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: 5.0 (LC50) 
Maximum LogKow: 6.4 (EC50) 
Maximum LogKow: 8.0 (ChV) 
Maximum Mol Wt: 1000 
  
Amides : 
------- 
No limitations known at this time. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: >8.5 (LC50) 
Maximum LogKow: >8.0 (EC50,ChV) 
Maximum Mol Wt: 1000 
  
Baseline Toxicity SAR Limitations: 
--------------------------------- 
Maximum LogKow: 5.0 (Fish 96-hr LC50; Daphnid LC50) 
Maximum LogKow: 6.4 (Green Algae EC50) 
Maximum LogKow: 8.0 (ChV) 
Maximum Mol Wt: 1000 
  
 
 
------------------------------------------------------------------------------ 
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RESULTS FOR DEGRADATE APF: 
 
 
 
SMILES : C#CCN1c2cc(c(cc2OCC1(=O))F)N 
CHEM   :  
CAS Num:  
ChemID1:  
ChemID2:  
ChemID3:  
MOL FOR: C11 H9 F1 N2 O2  
MOL WT : 220.20 
Log Kow: -0.10  (KowWin estimate) 
Melt Pt:   
Wat Sol: 2055 mg/L  (WskowWin estimate) 
 
ECOSAR v1.00a Class(es) Found 
------------------------------ 
Anilines (Aromatic Amines) 
Amides  
                                                                    Predicted 
ECOSAR Class                 Organism            Duration  End Pt   mg/L (ppm) 
===========================  ==================  ========  ======   ========== 
Anilines (Aromatic Amines) : Fish                96-hr     LC50      395.527 
Anilines (Aromatic Amines) : Fish                14-day    LC50     4398.546 * 
Anilines (Aromatic Amines) : Daphnid             48-hr     LC50        5.467 
Anilines (Aromatic Amines) : Green Algae         96-hr     EC50       16.379 
Anilines (Aromatic Amines) : Fish                          ChV         3.060 
Anilines (Aromatic Amines) : Daphnid                       ChV         0.159 
Anilines (Aromatic Amines) : Green Algae                   ChV        11.728 
 
Amides                     : Fish                96-hr     LC50     1303.225 
Amides                     : Daphnid             48-hr     LC50      355.168 
Amides                     : Green Algae         96-hr     EC50        1.863 
Amides                     : Fish                          ChV         7.704 
Amides                     : Daphnid                       ChV         4.685 ! 
Amides                     : Green Algae                   ChV         0.368 
 
===========================  ==================  ========  ======   ========== 
Neutral Organic SAR        : Fish                96-hr     LC50    10189.535 * 
(Baseline Toxicity)        : Daphnid             48-hr     LC50     4560.417 * 
                           : Green Algae         96-hr     EC50      829.939 
                           : Fish                          ChV      1013.287 
                           : Daphnid                       ChV       290.455 
                           : Green Algae                   ChV       204.628 
 
 Note:  * = asterisk designates: Chemical may not be soluble 
        enough to measure this predicted effect. 
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 Note:  ! = exclamation designates: The toxicity value was determined from 
     a predicted SAR using established acute-to-chronic ratios and ECOSAR 
     regression techniques which are documented in the supporting Technical 
     Reference Manual. When possible, this toxicity value should be 
     considered in a weight of evidence approach. 
  
Anilines (Aromatic Amines): 
-------------------------- 
  For Fish Acute Toxicity Values: 2,3,5,6-Tetrachloroaniline is 19 times 
more toxic than predicted by this SAR. Tetrabromoaniline may be more toxic 
than predicted by this SAR as well. 
  
  For Daphnid and Green Algae Toxicity Values: Tetrachloro- and tetrabrom- 
aniline may be 20 times toxic than predicted by this SAR. 
  
  N-Substituted anilines are less toxic than predicted by these SARs; 
for these compounds, Neutral Organic SARs are used. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: >7.8 (Fish 96-hr LC50, Daphnid 48-h LC50) 
Maximum LogKow: >3.7 (Fish 14-day LC50) 
Maximum LogKow: >4 (Green Algae 96-hr EC50 and ChV) 
Maximum LogKow: >4.3 (Fish ChV) 
Maximum LogKow: >2.4 (Daphnid ChV) 
Maximum Mol Wt: 1000 
  
Amides : 
------- 
No limitations known at this time. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: >8.5 (LC50) 
Maximum LogKow: >8.0 (EC50,ChV) 
Maximum Mol Wt: 1000 
  
Baseline Toxicity SAR Limitations: 
--------------------------------- 
Maximum LogKow: 5.0 (Fish 96-hr LC50; Daphnid LC50) 
Maximum LogKow: 6.4 (Green Algae EC50) 
Maximum LogKow: 8.0 (ChV) 
Maximum Mol Wt: 1000 
  
 
 
------------------------------------------------------------------------------ 
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RESULTS FOR DEGRADATE THPA: 
 
 
 
Input: 
 
SMILES : C1CCC(=C(C1)C(=O)O)C(=O)O 
CHEM   : 1,2,3,4-Tetrahydrophthalic acid  
CAS Num: 635-08-5 
ChemID1:  
ChemID2:  
ChemID3:  
MOL FOR: C8 H10 O4  
MOL WT : 170.17 
Log Kow: 2.02  (User entered) 
Melt Pt: 123.00 deg C 
Wat Sol: 1580 mg/L  (WskowWin estimate) 
 
 
ECOSAR v1.00a Class(es) Found 
------------------------------ 
Neutral Organics-acid 
    
                                                                 Predicted 
ECOSAR Class                 Organism            Duration  End Pt   mg/L 
(ppm) 
===========================  ==================  ========  ======   
========== 
--> Acid moeity found: Predicted values multiplied by 10 
 
Neutral Organics-acid      : Fish                96-hr     LC50     1259.435 
Neutral Organics-acid      : Fish                14-day    LC50     1273.843 
Neutral Organics-acid      : Daphnid             48-hr     LC50      712.295 
Neutral Organics-acid      : Green Algae         96-hr     EC50      341.061 
Neutral Organics-acid      : Fish                30-day    ChV       131.389 
Neutral Organics-acid      : Daphnid                       ChV        82.839 
Neutral Organics-acid      : Green Algae                   ChV       130.761 
Neutral Organics-acid      : Fish  (SW)          96-hr     LC50     1748.300 
* 
Neutral Organics-acid      : Mysid Shrimp        96-hr     LC50     1238.169 
Neutral Organics-acid      : Fish  (SW)                    ChV       185.553 
Neutral Organics-acid      : Mysid Shrimp (SW)             ChV       106.391 
Neutral Organics-acid      : Earthworm           14-day    LC50     2944.420 
* 
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 Note:  * = asterisk designates: Chemical may not be soluble 
        enough to measure this predicted effect. 
  
Neutral Organics: 
---------------- 
  For Fish LC50 (96-h), Daphnid LC50, Mysid: If the log Kow is greater 
than 5.0, or if the compound is solid and the LC50 exceeds the water 
solubility by 10X, no effects at saturation are predicted. 
  
  For Fish LC50 (14-day) and Earthworm LC50: If the log Kow is greater 
than 6.0, or if the compound is solid and the LC50 exceeds the water 
solubility by 10X, no effects at saturation are predicted. 
  
  For Green Algae Acute Toxicity Values: If the log Kow of the chemical is 
greater than 6.4, or if the compound is solid and the EC50 exceeds the water 
solubility by 10X, no effects at saturation are predicted for these 
endpoints. 
  
  For All Chronic Toxicity Values: If the log Kow of the chemical is greater 
than 8.0, or if the compound is solid and the ChV exceeds the water 
solubility 
by 10X, no effects at saturation are predicted for these endpoints. 
  
ECOSAR v1.00 SAR Limitations: 
---------------------------- 
Maximum LogKow: 5.0 (Fish 96-hr LC50; Daphnid LC50, Mysid LC50) 
Maximum LogKow: 6.0 (Fish 14-day LC50; Earthworm LC50) 
Maximum LogKow: 6.4 (Green Algae EC50) 
Maximum LogKow: 8.0 (ChV) 
Maximum Mol Wt: 1000 
----------------------------------------------------------------------------- 
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Appendix 2 
Estimated Environmental Concentrations (EECs) and Dissipation 
Behavior of Flumioxazin Following Direct Application to Water Using the 
AQUATOX Model 
 
Modeling of Concentration and Dissipation of Flumioxazin in Standard Pond 
AQUATOX is a model that is available from USEPA and has the capability to estimate the 
concentration in a water body from direct application of pesticides to a water body. AQUATOX 
is an ecosystem simulation model that predicts the fate of various pollutants, such as excess 
nutrients and organic chemicals, and their effects on aquatic ecosystems. An overview of the 
model is given below. For the purpose of the aquatic exposure assessment for the review 
presented here, the AQUATOX model was used to estimate the concentration and dissipation 
characteristics of flumioxazin in a standard pond. The fate portion of the model was used to here 
to characterize the dissipation of flumioxazin following an application to a standard pond. 
 
Brief overview of the AQUATOX Model 
AQUATOX is an ecosystem simulation model that predicts the fate of various pollutants, such as 
excess nutrients and organic chemicals, and their effects on aquatic ecosystems, including fish, 
invertebrates, and aquatic plants. AQUATOX is a valuable tool for ecologists, biologists, water 
quality modelers, and anyone who performs ecological risk assessments for aquatic ecosystems.  
AQUATOX simulates the transfer of biomass, energy and chemicals from one compartment of 
the ecosystem to another. It does this by simultaneously computing each of the most important 
chemical or biological processes for each day of the simulation period; therefore it is known as a 
process-based or mechanistic model. AQUATOX can predict not only the environmental fate of 
chemicals in aquatic ecosystems, but also their direct and indirect effects on the resident 
organisms. Therefore it has the potential to establish causal links between chemical water quality 
and biological response and aquatic life uses. 
AQUATOX is the only general ecological risk model that represents the combined 
environmental fate and effects of conventional pollutants, such as nutrients and sediments, and 
toxic chemicals in aquatic ecosystems. It considers several trophic levels, including attached and 
planktonic algae and submerged aquatic vegetation, invertebrates, and forage, bottom-feeding, 
and game fish; it also represents associated organic toxicants.  It has been implemented for 
streams, ponds, lakes, estuaries, reservoirs, and experimental enclosures.  
The fate portion of the model, which is applicable especially to organic toxicants, includes: 
partitioning among organisms, suspended and sedimented detritus, suspended and sedimented 
inorganic sediments, and water; volatilization; hydrolysis; photolysis; ionization; and microbial 
degradation. The effects portion of the model includes: acute toxicity to the various organisms 
modeled; and indirect effects such as release of grazing and predation pressure, increase in 
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detritus and recycling of nutrients from killed organisms, dissolved oxygen sag due to increased 
decomposition, and loss of food base for animals.   
  
AQUATOX is the latest in a long series of models, starting with the aquatic ecosystem model 
CLEAN (Park et al., 1974) and subsequently improved in consultation with numerous 
researchers at various European hydrobiological laboratories, resulting in the CLEANER series 
(Park et al., 1975, 1979, 1980; Park, 1978; Scavia and Park, 1976) and LAKETRACE (Collins 
and Park, 1989). The MACROPHYTE model, developed for the U.S. Army Corps of Engineers 
(Collins et al., 1985), provided additional capability for representing submersed aquatic 
vegetation. Another series started with the toxic fate model PEST, developed to complement 
CLEANER (Park et al., 1980, 1982), and continued with the TOXTRACE model (Park, 1984) 
and the spreadsheet equilibrium fugacity PART model. AQUATOX combined algorithms from 
these models with an ecotoxicological construct borrowed from the FGETS model (Suárez and 
Barber, 1992); and additional code was written as required for a truly integrative fate and effects 
model (Park, 1990, 1993).  In the late 1990s, AQUATOX was restructured and linked to 
Microsoft Windows interfaces to provide even greater flexibility, capacity for additional 
compartments, and user friendliness.   
  
• AQUATOX Release 1 was produced in 2002 and was the first EPA release to run under 
Windows.  
• AQUATOX Release 2 was completed in 2003 and included more state variables and 
multi-age-class fish along with a refined user-interface.  
• AQUATOX Release 2.1 was completed in 2005 and included additional chemical 
modeling options and variable stoichiometry among numerous other refinements.  
• AQUATOX Release 2.2 was completed in 2006 and included updated simulations and 
parameter databases along with minor interface enhancements.  
• AQUATOX Release 3 was completed in 2009 and includes linked segments, simulations 
of estuaries, dramatically improved output capabilities, and many other model 
improvements.  
In 2009, EPA released an enhanced version of AQUATOX, Release 3, which includes the 
capability to represent estuaries and to more realistically model nutrients. More information on 
the model and its applications, including references to peer-reviewed publications, is available at 
http://www.epa.gov/waterscience/models/aquatox/. 
 
Model Input 
The model package contains a number of scenarios. The model guidance suggests to select a 
scenario from the model package, and modify it as needed to make it more representative for a 
specific situation and conditions. The model results are suggested to be used for screening-level 
assessments. For the purpose of the review presented here, the model was used to simulate the 
fate of flumioxazin in the default Missouri farm pond. The study on esfenvalerate in a Missouri 
Farm Pond was selected as a starting scenario. The state variables defined for this model scenario 
and their initial values are listed in the attached Table A2.1.  The site characteristics and 
chemical parameters are available upon request from H. Wijnja, MDAR.  
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The site characteristic for the latitude was adjusted to 42 degrees in order to make it more 
representative for the light situation in MA. The dimensions of the pond were modified to 
represent the dimensions of the EPA standard pond: Surface area of 1 ha (10000 m2), a depth of 
2 m (6.56 ft), and a resulting volume of 20,000 m3. Subsequently, depths of 1.2 m (3.94 ft), 0.91 
m (3 ft) and 0.304 m (1ft) (with associated volumes) of this pond were also simulated.  
Chemical Properties and Fate Data were adjusted to be representative of flumioxazin and its 
degradates. The following parameter values were used (see also Section 2.4 in main document): 
Molecular weight: 384; Henry’s Law constant: 6.2E-7 atm m3 mol-1; Octanol-water partitioning 
constant (log): 2.55; Water partitioning coefficient: 50 L/kg; rate of aerobic and anaerobic 
microbial degradation: 0.00001 d-1(set at a low value); maximum rate of hydrolysis: 0.693 d-1 
(calculated using the half life value of 1 d and k = ln(2)/half life); and photolysis rate: 0.693 d-1 
(based on half-life of 1 d). The model parameter input for degradation processes was 
conservative in that it assumed hydrolysis and photolysis as the major degradation processes. 
Modeling results that included simulation of aerobic microbial degradation with a half-life of 3 
days indicated slightly faster degradation and a slightly lower peak value of flumioxazin. The 
model results presented below are therefore conservative estimates of flumioxazin 
concentrations.  
 
The herbicide application was programmed to occur on May 10th considering a scenario with the 
highest aquatic exposure level of an application to submerged vegetation with a maximum 
concentration of 200 ppb. Repeat applications were not considered since these are not used in 
practice. The amount of flumioxazin for model input was determined based on the concentration 
of 200 ppb in the volume of the water body modeled, which is based on the depths considered. 
The amounts of flumioxazin applied was 1823 g for a pond with a depth of 0.91 m (3 ft)  The 
model simulation was run from May 1st through August 31st.  
 
The modeling also included the simulation of major degradates of flumioxazin. The load data 
and individual chemical parameters were defined in the model input. 
  
The degradation of flumioxazin was assumed to take place by first degrading to 482-HA with a 
dissipation half-live of 1 day.  Subsequently, it was assumed that 482-HA degraded to APF and 
THPA in equal fractions at a rate corresponding with a half-live of 4.9 days (corresponding rate 
is 0.138 d-1). APF and THPA were assumed to degrade at a rate corresponding to a half-live of 
10.5 days (corresponding rate is 0.066 d-1).  The degradation parameters for microbial 
degradation, hydrolysis and photolysis were all set at the same value representing the dissipation 
rate stated above.  
 
The modeling was performed in three steps. First, the model was run with the application of 
flumioxazin taking place at the selected dates  and application rates. The loss data for 
flumioxazin generated by the model were then used to determine the load data for the primary 
degradate 482-HA. The model was then run again, this time also with the load data for 482-HA 
(in addition to the loading of flumioxazin). The simulated loss data for 482-HA were then used 
to determine the loading of APF + THPA. The model was then run a third time to generate the 
concentration profiles that included also APF and THPA (sum of these two degradates).   
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Results 
From the model output, the dissolved flumioxazin, 482-HA, and APF/THPA concentrations were 
selected. The results are presented in the graph below.  
 
 
 
Figure A2.1  Aquatic concentrations of flumioxazin and its major degradates simulated by the AQUATOX model. 
The concentration profiles are the result of a single application at 200 ppb initial flumioxazin concentration on day 
10 (May 10th). The degradation rates were based on half-lives observed in an aquatic field study in Iowa  
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Table A2.1   State Variables for Missouri Farm Pond and their initial values 
State Variable 
Name Init. Cond. Units 
NH3 & NH4+ 0.08 mg/L 
NO3 0.05 mg/L 
Tot. Sol. P 0.05 mg/L 
CO2 1.5 mg/L 
Oxygen 12 mg/L 
R detr sed 3 g/m2 dry 
L detr sed 3 g/m2 dry 
R detr diss 0.72 mg/L dry 
L detr diss 0.18 mg/L dry 
R detr part 0.08 mg/L dry 
L detr part 0.02 mg/L dry 
BuryRDetr 2 g/m2 
BuryLDetr 2 g/m2 
Peri High-Nut 
Diatom 36.86 g/m2 dry 
Phyt High-Nut 
Diatom 0.00 mg/L dry 
Peri, Green 0.01 g/m2 dry 
Phyto, Green 0.00 mg/L dry 
Phyt, Blue-Greens 0.00 mg/L dry 
Cryptomonas 0.07 mg/L dry 
Myriophyllum 36.67 g/m2 dry 
Chironomid 2.29 g/m2 dry 
Daphnia 0.05 mg/L dry 
Copepod 0.32 mg/L dry 
Sphaerid 2.46 g/m2 dry 
Mayfly (Baetis) 0.24 g/m2 dry 
Rotifer, Keratella 0.07 mg/L dry 
Gastropod 3.68 g/m2 dry 
Shiner 4.02 g/m2 dry 
Largemouth Bass, 
YOY 0.21 g/m2 dry 
Largemouth Bass, 
Lg 4.43 g/m2 dry 
Water Vol 9114 cu.m 
Temp 16 deg. C 
Wind 0 m/s 
Light 333 Ly/d 
pH 6.8 pH 
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Appendix 3 
Information Related to Exposure and Risk Assessment of 
Flumioxazin 
 
The information is supplementary to the text in the main review document section on exposure 
and ecological risk assessment (Section 3.2 and 3.3) and was taken from USEPA (2010A).  
 
Terrestrial Exposure Assessment 
USEPA or EFED (2010) assessed the risk to avian and terrestrial species based on a worst-case 
exposure scenario considering that the entire application (0.383 lbs ai/A) being applied to the 
shoreline multiple times during the season. Exposure to birds and mammalian species was based 
on residues on various food items.   This scenario would be highly conservative since the 
maximum surface application is not expected to be applied to any non-aquatic area. The 
maximum EEC on short grass was 206 ppm, 116 ppm on tall grass, 95 ppm on broadleaf plants 
and insects, and 13 ppm on seeds, fruits, and large insects.  
 
The terrestrial exposure assessment is based on the methods of Hoerger and Kenaga (1972)5 as 
modified by Fletcher et al. (1994)6.  Uncertainties in the terrestrial EECs are primarily associated 
with a lack of data on interception and subsequent dissipation from foliar surfaces.  EFED 
assumes that the foliar dissipation rate is equal to the aerobic soil metabolism rate.  Open 
literature data suggest that foliar dissipation rates are generally less than 20 days7. 
 
Estimated Environmental Concentrations on Avian and Mammalian Food Items (ppm) following for 
scenario with 0.383 lbs ai/Acre x 6 applications with 28-day intervals (worst-case scenario) 
 
Food Items 
EEC (ppm) 1 
Predicted Maximum Residue 
 
Short range grass 206.57  
Tall grass 116.2  
Broadleaf plants and small insects 94.68  
Fruits, pods, seeds, and large insects 12.91  
 
1
 EECs are based on Hoerger and Kenega (1972), modified by Fletcher et al (1994). For multiple applications, EFED used EECs 
based on Hoerger and Kenega (1972) and Fletcher et al (1994), with first-order dissipation from foliage between applications (a 
35 day default half life was used to calculate EECs) 
                                                 
1 Hoerger, F., and E.E. Kenaga.  1972.  Pesticide residues on plants: Correlation of representative data as a basis for 
estimation of their magnitude in the environment.  In F. Coulston and F. Korte, eds., Environmental Quality and Safety: 
Chemistry, Toxicology, and Technology, Georg Thieme Publ, Stuttgart, West Germany, pp. 9-28. 
2 Fletcher, J.S., J.E. Nellessen, and T.G. Pfleeger.  1994.  Literature review and evaluation of the EPA food-chain 
(Kenaga) nomogram, an instrument for estimating pesticide residues on plants.  Environ. Tox. Chem. 13:1383-1391. 
3 Knisel, W.G., ed. 1980.  CREAMS: A field-scale model for chemicals, runoff, and erosion from agricultural 
management systems.  USDA Conserv. Res. Rep. No. 26). 
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Risk presumptions, along with the corresponding Risk Quotients (RQs) and Levels of 
Concern (LOCs) are tabulated below: 
 
Risk Presumptions for Terrestrial Animals 
Risk Presumption RQ LOC 
Birds 
Acute High Risk EEC1/LC50 or LD50/sqft2 or LD50/day3 0.5 
Acute Restricted Use EEC/LC50 or LD50/sqft or LD50/day (or LD50 < 50 mg/kg) 0.2 
Acute Endangered Species EEC/LC50 or LD50/sqft or LD50/day  0.1 
Chronic Risk EEC/NOAEC 1 
Wild Mammals 
Acute High Risk EEC/LC50 or LD50/sqft or LD50/day  0.5 
Acute Restricted Use EEC/LC50 or LD50/sqft or LD50/day (or LD50 < 50 mg/kg) 0.2 
Acute Endangered Species EEC/LC50 or LD50/sqft or LD50/day  0.1 
Chronic Risk  EEC/NOAEC 1 
 
1
  abbreviation for Estimated Environmental Concentration (ppm) on avian/mammalian food items    
 
2
    mg/ft2               3  mg of toxicant consumed/day 
   LD50 * wt. of bird                  LD50 * wt. of bird   
  
 
Risk Presumptions for Aquatic Animals   
Risk Presumption RQ  LOC 
Acute High Risk EEC1/LC50 or EC50 0.5 
Acute Restricted Use EEC/LC50 or EC50 0.1 
Acute Endangered Species EEC/LC50 or EC50 0.05 
Chronic Risk EEC/MATC or NOAEC 1 
 
1
  EEC = (ppm or ppb) in water 
 
 
Risk Presumptions for Plants   
Risk Presumption RQ LOC 
Terrestrial and Semi-Aquatic Plants  
Acute High Risk EEC1/EC25 1 
Acute Endangered Species EEC/EC05 or NOAEC 1 
  Aquatic Plants 
Acute High Risk EEC2/EC50 1 
Acute Endangered Species EEC/EC05 or NOAEC  1 
1
  EEC = lbs ai/A  
2
  EEC = (ppb/ppm) in water  
 
Risk Characterization Data 
Freshwater Fish 
Risk Quotients for Freshwater Fish Based On a EC50/LC50 of 2.3 ppm and a NOAEC of 0.0077 ppm 
 
 
 
 
 
LC50 
(ppm) 
NOAEC 
(ppm) 
EEC 
Initial/Peak 
(ppm) 
EEC 
60-Day Ave. 
(ppm) 
Acute RQ  
(EEC/LC50) 
Chronic RQ 
(EEC/NOAEC) 
Flumioxazin 2.3 0.0077 0.4 0.025 0.17 3.25 
482-HA 2.3 0.0077 0.0216 0.0216 0.00 2.80 
APF 2.3 0.0077 0.110 0.110 0.047 14.28 
THPA 2.3 0.0077 0.0889 0.0889 0.038 11.54 
       
 
 
  
 
3-3 
 
Freshwater Invertebrates 
Risk Quotients for Freshwater Invertebrates Based On a EC50/LC50 of 5.5 ppm and a NOAEC of 0.028 ppm. 
 
 
Rate 
LC50 
(ppm) 
NOAEC 
(ppm) 
EEC 
Initial/Peak 
(ppm) 
EEC 
21-Day  
Average (ppm) 
Acute RQ  
(EEC/LC50) 
Chronic RQ 
(EEC/NOAEC)  
 Flumioxazin 5.5 0.028 0.4 0.00 0.07 0.00 
482-HA 5.5 0.028 0.0216 0.0216 0.00 0.77 
ADF 5.5 0.028 0.110 0.110 0.02 3.93 
THPA 5.5 0.028 0.0889 0.0889 0.01 3.17 
       
     
 
Birds: Acute and Chronic, Multiple Applications 
Avian Acute and Chronic Risk Quotients for multiple Broadcast Applications of Flumioxazin, based on a n Avian LC50 of 5620 
ppm  and NOAEC of 250 ppm .  
Use/App. 
Method 
Rate (Ibs ai/A) x 
No. Apps. 
 
Food Items 
Max EEC (ppm) 1 Acute RQ 
(Max EEC/LC50) 
Chronic RQ (Max 
EEC/ NOAEC) 
 Multiple Applications2 
Aquatic Surface 0.383 x 6 
(28-da interval) 
Short grass 206.57 0.04 0.82 
Tall grass 116.2 0.02 0.50 
Broadleaf plants/Insects 94.68 0.02 0.38 
Seeds 12.91 <0.01 0.05 
 Levels of Concern (LOC) 
Endangered species may be affected (acute risk) > 0.1  
Acute risk may be mitigated through restricted use, in addition to endangered species risk > 0.2  
High acute risk, including endangered species > 0.5  
Chronic risk, including endangered species  > 1 
1
 EECs are based on Hoerger and Kenega (1972), modified by Fletcher et al (1994). 
2
 For multiple applications, EFED uses EECs based on Hoerger and Kenega (1972) and Fletcher et al (1994), with first-order 
dissipation from foliage between applications (a 35 day default half life was used to calculate EECs) 
 
Mammals 
Mammalian Acute  
The residues expected on mammalian food items after aquatic applications of Flumioxazin 
products are based on the highest residue concentrations immediately after application (Fletcher, 
1994). The results suggest that mammalian acute levels of concern are not exceeded even under 
the highest multiple application rate.  This scenario would be highly conservative since the 
maximum surface application is not expected to be applied to any non-aquatic area, thus no risk 
is assumed. 
 
Mammalian Chronic (multiple applications) 
The following tables summarize the mammalian chronic risk quotients for single and multiple 
broadcast applications of non-granular products based on rat reproductive toxicity data.  
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Mammalian (Rat) chronic risk quotients for multiple broadcast spray applications of Flumioxazin, based on a rat 
NOAEC of 100 ppm  in the diet using a 35 day halflife.  
 
 
Use/App. 
Method 
 
 
Rate (Ibs ai/A) x 
No. Apps. 
 
 
 
Food Items 
 
 
Max/Ave EEC 
(ppm) 1 
 
Chronic RQ (EEC/NOAEC) 
Max/Ave 
 Multiple Application2 
Aquatic Surface 0.383 x 6 x 28 da Short grass 206.57 2.06 
Tall grass 116.19 1.16 
Broadleaf plants/Insects 94.68 0.94 
Seeds 12.91 0.12 
 Levels of Concern  
Chronic risk > 1.0 
1
 EECs are based on Hoerger and Kenega (1972), modified by Fletcher et al (1994). 
2
 For multiple applications, EFED uses EECs based on Hoerger and Kenega (1972) and Fletcher et al (1994), with first-order 
dissipation from foliage between applications.  If foliar dissipation data are not available, a 35 day default value is used.  
 
Risk to Plants 
Terrestrial Plant Acute Risk Quotients For Flumioxazin (Endangered and Non-Endangered) 
Crop 
Details/Rate 
EECs (lbs a.i./acre) 1EC25 or NOEC RQ 
Total Loading 
to Adjacent 
Dry Areas  
Total Loading 
to Semi-
Aquatic Areas 
 
Total 
Drift 
Seedling 
Emergence 
(Monocots 
and Dicots) 
Vegetativ
e Vigor 
(Monocot
s and 
Dicots) 
Emergence 
RQs-Adjacent 
Dry Areas 
(Monocots and 
Dicots) 
Emergence 
RQs, Semi-
Aquatic Areas 
(Monocots and 
Dicots) 
Drift RQ 
(Monocots 
and Dicots) 
Non-Endangered 
Aquatic 
0.38 lbs ai/A 
0.0077-0.0214 0.0421 0.0038-
0.0192 
0.0037 
0.0008 
0.0071 
0.00008 
2.07-5.80 
9.58-26.81 
11.39 
52.66 
0.54-2.70 
47.88-239.4 
Endangered 
Aquatic 
0.38 lbs ai/A 
0.0077-0.0214 0.0421 0.0038-
0.0192 
0.003 
0.0004 
0.006 
0.00005 
2.55-7.15 
19.15-53.62 
14.04 
105.33 
0.64-3.19 
76.60-383.00 
 
Acute Non-endangered Plant RQ = EEC/EC25;  Acute Endangered Plant RQ = EEC/EC05 or NOEC;  
1
 EC25 for Non-endangered and NOEC for Endangered 
Levels of Concern: RQ∃1.0 = Acute Risk 
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Appendix 4 
Refined Aquatic Risk Assessment for Flumioxazin and 
Degradates 
 
 
A refined aquatic risk assessment was conducted to supplement the results from EPA’s aquatic 
risk assessment. EPA’s aquatic risk assessment indicated LOC exceedances for various risk 
presumption categories, however, EPA did not provide a refined risk assessment.  Results of 
refined assessments are presented below. The risk assessment was refined by additional  
exposure assessments (AQUATOX-modeling by DAR (Appendix 2) and Iowa Pond monitoring 
data), estimated ecotoxicological endpoints for degradates (Appendix 1), and concentration 
addition for assessing the risk of combined effects from flumioxazin and degradates.  
 
A risk assessment for water ingestion by muskrats and beavers was also performed.  In that case, 
in the absence of quantitative toxicity estimates for the degradates, the toxicities of all the 
degradates except for THPA were assumed to be equivalent to that of flumioxazin and risks were 
calculated in aggregate across compounds.  THPA was omitted as USEPA has judged its toxicity 
to be less than that of the parent and other degradates. 
 
Risk Assessment Based on Estimated Toxicity Endpoints for Degradates 
The aquatic organism risk assessment was refined by considering the estimated ecotoxicity 
endpoints for the degradates. The adjusted values were calculated based on the toxicity endpoint 
point values for flumioxazin (available data for LC50 and EC50 data). The degradate endpoints 
were calculated by multiplying the endpoint point value for flumioxazin (study data) by the ratio 
of ECOSAR-predicted degradate endpoint / ECOSAR-predicted endpoint for flumioxazin (Table 
A1-2 in Appendix 1). The refined assessment was done for the DAR exposure assessment 
(AQUATOX estimated EECs). The results are shown in Table 3 for freshwater fish and Table 4 
for freshwater invertebrates. The results for estuarine/marine fish and invertebrates are shown in 
Fig. 6 and 7. 
 
The combined (totals) ecorisk quotients presented in Table 1 and 2 was based on the assumption 
that the toxicity of parent and degradates are the same. In addition, it was assumed that 
concentrations of parent and degradates are additive, but this may not be the case if, for example, 
peak concentrations of parent and degradates occur at different times.  
 
Risk Assessment Based on Concentration Addition Approach for Combined Effects 
The combined effect of multiple substances can also be assessed by using the concentration 
additions approach. The combined effect of multiple compounds or substances is calculated by 
summation of the concentration divided by an effect concentration. This approach is considered 
to provide a conservative estimate of the mixture effect (Junghaus et al., 2006; Backhaus and 
Faust, 2012; Lydy et al., 2004). The concentration addition is commonly applied by the use of 
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toxic units (TU). The TU is defined as the quotient ci/ECxi which rescales the absolute 
concentrations of substances to individual potencies. The combined effect is estimated by the 
summation of TUs.  This approach was used in a refined assessment of the combined effect of 
flumioxazin and its degradates. The refined assessment was based on the AQUATOX-derived 
EECs and refined assessment of toxicity endpoints of the degradates based on ECOSAR 
predictions (Appendix 2).  
 
The toxic unit summation results for fish and invertebrates are included in Table 3 and 4 
(freshwater) and Table 6 and 7 (estuarine/marine).  
 
  
Table 1.  Comparison of Modeling and Monitoring Information for Risk Assessment in Freshwater Fish. Toxicity 
of degradates was assumed to be equal to flumioxazin. Total concentrations are summation of flumioxazin 
and all degradates (shading denotes trigger of acceptable LOC level) 
(bolding represents total RQs that exceed LOCs for endangered fish (acute) or fish (chronic) 
Compound  Peak1 
(ppb) 
21-d avg 
(ppb) 
60-d avg 
(ppb) 
Acute RQ 
(EEC/LC50)2   
Chronic RQ 
(EEC/NOAEC)3 
    21-d                     60-d 
Flumioxazin EPA5 400 38 39 0.17 4.9 5.1 
 DAR6 200 15.7 5.65 0.085 2.04 0.73 
 Iowa7 233 15.6 (7-d) 2.21 (28-d) 0.10 2.03 (7-d) 0.29 (28-d) 
482-HA EPA 21.6 21.6 21.6 0.009 2.8 2.8 
 DAR 104 37.5 13.7 0.045 4.87 1.8 
 Iowa 320 12.4 (14-d) 3.31 (28-d) 0.14 1.61 (14-d)  0.43 (28-d) 
APF EPA 110.1 110.1 110.1 0.05 14.2 14.2 
 DAR 37.3 21.7 11.5 0.02 2.82 1.5 
 Iowa 15.8 1.99 (7-d) 1.21 (28-d) 0.007 0.26 (7-d)  0.16 (28-d) 
THPA EPA 88.9 88.9 88.9 0.04 11.5 11.5 
 DAR 37.3 21.7 11.5 0.02 2.82 1.5 
 Iowa --- --- --- --- --- --- 
Totals EPA 421.68 220.6 245.6 0.189 28.7 31.9 
 DAR 2208 96.6 42.2 0.13 12.6 5.5 
 Iowa 5538 ---4 6.73 0.24 ---4 0.87 (28-d) 
1
The peak value for the EPA study is the maximum immediately following application; for the DAR study, is the initial 
concentration that has been subject to degradation with a half-life of one day; and for the Iowa study, is the concentration 2 
hours following application. 
2
 LC50 = 2300 ppb; Acute High Risk LOC = 0.5; Acute Restricted Use = 0.1; Acute Endangered Species = 0.05: Acute EEC is peak 
level, chronic EEC used by EPA is 60-d average for fish (http://www.epa.gov/oppefed1/ecorisk_ders/toera_risk.htm) 
3
NOAEC = 7.7 ppb; Chronic Risk LOC = 1.0 
4
The total for this column for the Iowa study was not calculated because the individual values represent two different durations 
in time. 
5
Exposure data based on three consecutive applications at 400 ppb in 28-d intervals  
6
Exposure data based on a single application at 200 ppb and AQUATOX-modeling (Appendix 2) 
7
Exposure data based on single application of 400 ppb 
8
 Total acute exposure is sum of flumioxazin and 482-HA 
9
 Total RQ calculation assumed equal toxicity of flumioxazin and its degradates  
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Table 2.  Comparison of Modeling and Monitoring Information for Risk Assessment in Freshwater 
Invertebrates.  Toxicity of degradates was assumed to be equal to flumioxazin. Total concentrations are 
summation of flumioxazin and all degradates (shading denotes trigger of acceptable LOC level) 
(bolding represents total RQs that exceed LOCs for endangered organisms (acute) or (chronic) 
 
 Compound  Peak1 
(ppb) 
21-d avg 
(ppb) 
60-d avg 
(ppb) 
Acute RQ 
(EEC/LC50)2   
Chronic RQ 
(EEC/NOAEC)2 
    21-d                     60-d 
Flumioxazin EPA5 400 38 39 0.07 1.35 1.39 
 DAR6 200 15.7 5.65 0.035 0.56 0.20 
 Iowa7 233 (2-h) 15.6 (7-d) 2.21 (28-d) 0.04 0.56 (7-d) 0.08 (28-d) 
482-HA EPA 21.6 21.6 21.6 0.004 0.77 0.77 
 DAR 104 37.5 13.7 0.02 1.34 0.49 
 Iowa 320 12.4 (14-d) 3.31 (28-d) 0.06 0.44 (14-d)  0.12 (28-d) 
APF EPA 110.1 110.1 110.1 0.02 3.9 3.9 
 DAR 37.3 21.7 11.5 0.01 0.78 0.41 
 Iowa 15.8 1.99 (7-d) 1.21 (28-d) 0.003 0.07 (7-d)  0.04 (28-d) 
THPA EPA 88.9 88.9 88.9 0.02 3.18 3.18 
 DAR 37.3 21.7 11.5 0.01 0.78 0.41 
 Iowa --- --- --- --- --- --- 
Totals 5 EPA 421.68 220.6 245.6 0.11 7.8 8.77 
 DAR 2208 96.6 42.2 
 0.054 3.44 1.51 
 Iowa 5538 ---3 6.73 0.10 ---3 0.24 (28-d) 
1
The peak value for the EPA study is the maximum immediately following application; for the DAR study, is the initial 
concentration that has been subject to degradation with a half-life of one day; and for the Iowa study, is the concentration 2 
hours following application. 
2
 LC50 = 5500 ppb; Acute High Risk LOC = 0.5; Acute Restricted Use = 0.1 (LOC for acute restricted use does not apply in the case 
of flumioxazin since it is not classified as a restricted use pesticide); Acute Endangered Species = 0.05; 
3
NOAEC = 28 ppb; 
Chronic Risk LOC = 1.0 
4
The total for this column for the Iowa study was not calculated because the individual values represent two different durations 
in time. 
5
Exposure data based on three consecutive applications at 400 ppb in 28-d intervals  
6
Exposure data based on a single application at 200 ppb and AQUATOX modeling (Appendix 2) 
7
Exposure data based on single application of 400 ppb 
8
Total acute exposure is sum of flumioxazin and 482-HA 
9
 Total RQ calculation assumed equal toxicity of flumioxazin and its degradates 
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  Table 3.  Refined Risk Assessment for Freshwater Fish based on estimated toxicity for the degradates,  
AQUATOX-modeled exposure data, and toxic unit summation for combined effects. (shading denotes trigger 
of acceptable LOC level)(bolding represents total RQs that exceed LOCs for endangered species 
Compound  Peak1 
(ppb) 
21-d avg1 
(ppb) 
60-d avg1 
(ppb) 
Acute RQ 
(EEC/LC50)2   
Chronic RQ 
(EEC/NOAEC)3 
    21-d                     60-d 
Flumioxazin DAR6 200 15.7 5.65 0.085 2.03 0.73 
482-HA DAR 104 37.5 13.7 0.001 0.015 0.006 
APF DAR 37.3 21.7 11.5 0.001 0.091 0.048 
THPA DAR 37.3 21.7 11.5 0.0002 0.002 0.001 
Toxic Unit 
Summation 
 
 
  0.052 2.14 0.789 
1
The exposure data are based on MDAR assessment using AQUATOX estimated concentrations for a single application at 200 
ppb (see Appendix 2). 
2
 Flumioxazin LC50 = 2300 ppb; Toxicity endpoints for 482-HA, APF and THPA were estimated by multiplying the 
flumioxazin endpoint value by the ratio of degradate value/flumioxazin value for ECOSAR predicted values listed in 
Table 5;  Acute High Risk LOC = 0.5; Acute Restricted Use = 0.1; Acute Endangered Species = 0.05: Acute EEC is peak level, 
chronic EEC is 21-d and 60-d average 
3
 Flumoxazin NOAEC = 7.7 ppb; 482-HA, APF and THPA: 7.7 ppb multiplied by the by the ratio of predicted endpoint of 
degradate/predicted endpoint of flumioxazin (see Table 5);  Chronic Risk LOC = 1.0 
 
 
  Table 4.  Refined Risk Assessment in Freshwater Invertebrates based on estimated toxicity for the 
degradates, AQUATOX-modeled exposure data, and toxic unit summation for combined effects. (shading 
denotes trigger of acceptable LOC level) (bolding represents total RQs that exceed LOCs for endangered 
invertebrates (acute) or fish (chronic) 
Compound  Peak1 
(ppb) 
21-d avg1 
(ppb) 
60-d avg1 
(ppb) 
Acute RQ 
(EEC/LC50)2   
Chronic RQ 
(EEC/NOAEC)3 
    21-d                     60-d 
Flumioxazin DAR6 200 15.7 5.65 0.035 0.56 0.202 
482-HA DAR 104 37.5 13.7 0.0002 0.002 0.001 
APF DAR 37.3 21.7 11.5 0.014 0.727 0.387 
THPA DAR 37.3 21.7 11.5 0.0001 0.001 0.001 
Toxic Unit 
Summation 
 
 
  0.035 1.29 0.59 
1
The exposure data are based on MDAR assessment using AQUATOX estimated concentrations for a single application at 200 
ppb (see Appendix 2). 
2
 Flumioxazin LC50 = 5500 ppb; Toxicity endpoints for 482-HA, APF and THPA were estimated by multiplying the 
flumioxazin endpoint value by the ratio of degradate value/flumioxazin value for ECOSAR predicted values listed in 
Table 5;  Acute High Risk LOC = 0.5; Acute Restricted Use = 0.1; Acute Endangered Species = 0.05: Acute EEC is peak level, 
chronic EEC is 21-d and 60-d average 
3
 Flumioxazin NOAEC = 28 ppb; 482-HA, APF and THPA: 28 ppb multiplied by ratio of predicted endpoint of degradate/predicted 
endpoint of flumioxazin (see Table 5); Chronic Risk LOC = 1.0 
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Table 5.  Ratios of degradate/flumioxazin for ECOSAR-estimated toxicity endpoint values (see also Table 2 in 
Appendix 1) 
 Ratio Degradate/Flumioxazin (acute) Ratio Degradate/Flumioxazin (chronic) 
 
Fish 96-hr 
LC50 
Daphnid 
48-h LC50 
 Fish Daphnid  
Flumioxazin 1 1  1 1  
482-HA 75.6 89.6  320.0 586.7  
APF 23.7 0.5  31.0 1.1  
THPA 75.4 62.5  1310.0 553.3  
 
 
  Table 6.  Refined Risk Assessment for Estuarine/Marine Fish based on estimated toxicity for the 
degradates,  AQUATOX-modeled exposure data, and toxic unit summation for combined effects. (shading 
denotes trigger of acceptable LOC level)(bolding represents total RQs that exceed LOCs for endangered 
species 
Compound  Peak1 
(ppb) 
21-d avg1 
(ppb) 
60-d avg1 
(ppb) 
Acute RQ 
(EEC/LC50)2   
Chronic RQ 
(EEC/NOAEC)3 
    21-d                     60-d 
Flumioxazin DAR6 200 15.7 5.65 0.043 2.03 0.73 
482-HA DAR 104 37.5 13.7 0.0003 0.015 0.006 
APF DAR 37.3 21.7 11.5 0.0003 0.091 0.048 
THPA DAR 37.3 21.7 11.5 0.0001 0.002 0.001 
Toxic Unit 
Summation 
 
 
  0.044 2.14 0.789 
1
The exposure data are based on MDAR assessment using AQUATOX estimated concentrations for a single application at 200 
ppb (see Appendix 2). 
2
 Flumioxazin LC50 = 4700 ppb; Toxicity endpoints for 482-HA, APF and THPA were estimated by multiplying the 
flumioxazin endpoint value by the ratio of degradate value/flumioxazin value for ECOSAR predicted values listed in 
Table 5;  Acute High Risk LOC = 0.5; Acute Restricted Use = 0.1; Acute Endangered Species = 0.05: Acute EEC is peak level, 
chronic EEC is 21-d and 60-d average 
3
 Flumoxazin NOAEC = 7.7 ppb (fresh water fish); 482-HA, APF and THPA: 7.7 ppb multiplied by the by the ratio of predicted 
endpoint of degradate/predicted endpoint of flumioxazin (see Table 5);  Chronic Risk LOC = 1.0 
 
 
  Table 7.  Refined Risk Assessment in Estuarine/Marine Invertebrates based on estimated toxicity for the 
degradates, AQUATOX-modeled exposure data, and toxic unit summation for combined effects. (shading 
denotes trigger of acceptable LOC level) (bolding represents total RQs that exceed LOCs for endangered 
invertebrates (acute) or fish (chronic) 
Compound  Peak1 
(ppb) 
21-d avg1 
(ppb) 
60-d avg1 
(ppb) 
Acute RQ 
(EEC/LC50)2   
Chronic RQ 
(EEC/NOAEC)3 
    21-d                     60-d 
Flumioxazin DAR6 200 15.7 5.65 0.87 1.045 0.377 
482-HA DAR 104 37.5 13.7 0.0051 0.004 0.002 
APF DAR 37.3 21.7 11.5 0.336 1.357 0.722 
THPA DAR 37.3 21.7 11.5 0.0026 0.003 0.001 
Toxic Unit 
Summation 
 
 
  1.213 2.409 1.101 
1
The exposure data are based on MDAR assessment using AQUATOX estimated concentrations for a single application at 200 
ppb (see Appendix 2). 
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2
 Flumioxazin LC50 = 230 ppb; Toxicity endpoints for 482-HA, APF and THPA were estimated by multiplying the 
flumioxazin endpoint value by the ratio of degradate value/flumioxazin value for ECOSAR predicted values listed in 
Table 5;  Acute High Risk LOC = 0.5; Acute Restricted Use = 0.1; Acute Endangered Species = 0.05: Acute EEC is peak level, 
chronic EEC is 21-d and 60-d average 
3
 Flumioxazin NOAEC = 15 ppb; 482-HA, APF and THPA: 28 ppb multiplied by ratio of predicted endpoint of degradate/predicted 
endpoint of flumioxazin (see Table 5); Chronic Risk LOC = 1.0 
 
 
Risk Assessment for Terrestrial Animals – Muskrats and Beavers  
The risks from exposures of beavers and muskrats to flumioxazin and its degradates were 
evaluated for drinking water exposures using an approach similar to that used for human 
drinking water exposures: compare duration-specific doses from herbicides in ingested water to 
duration-specific oral reference doses for these small mammals calculated from rodent studies 
reviewed in Section 2.1 of the main report. 
 
Exposure parameters (body weights and daily water ingestion rates for muskrats and beavers 
(Table 8) were taken from compendia of wildlife exposure factors. 
 
Table 8. Exposure Factors Used in Muskrat and Beaver Risk Assessments 
Species Body weight, kg Water ingestion rate, 
L/d 
Source 
muskrat 1.4 1.372 US EPA, 1993 
beaver 19.31 1.42 US EPA, 1999 
rat (Sprague Dawley) 0.15 (6-7 wk old) - Charles River 
Laboratories (n.d.) 
 
Species-specific reference doses of the flumioxazin/degradates together were calculated from the 
acute and chronic NOAELs identified by USEPA (2011a) from the developmental/reproductive 
rat study by Kawamura (1995) showing cardiovascular defects with short-term exposures and 
increased chronic nephropathy in males and decreased hematological parameters in females with 
longer-term exposures.  In the absence of mammalian toxicity data for the degradates of 
flumioxazin, the toxicities of the major degradates 482-HA and APF were assumed to be 
equivalent to that for flumioxazin. THPA was not included in the risk evaluation because the 
USEPA in its review judged it to have significantly lower toxicity than the parent and the other 
degradates (Section 2.4 of main report). 
   
Rat NOAELS (mg/kg) were converted from rat doses into beaver or muskrat equivalent doses 
using body weight scaling to the ¾ power following guidance provided by USEPA (2011b). 
These species specific equivalent NOAEL doses were then divided by a residual default 
uncertainty factor of 3 for interspecies differences to arrive at oral reference dose (RfD) values. 
Acute and chronic RQs were calculated by dividing the duration specific water-derived doses by 
the RfDs (Table 9). 
 
Risks from other exposure routes such as dermal absorption, preening, inhalation, vegetation 
ingestion are likely insignificant given the very low RQs calculated for direct water ingestion. 
The exposures from these other routes would have to be almost two orders of magnitude greater 
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than that for ingestion for the total risks to approach the LOC of 1: a very unlikely event. For 
comparison, exposures of humans to volatile organic chemicals (VOCs) in the home from use of 
VOC contaminated water via dermal absorption and from inhalation of volatilized chemicals 
from water may be equivalent to that of that from ingestion, but these are for lipophilic, volatile 
chemicals whereas the flumioxazin and its degradates are relatively water soluble and therefore 
not amenable to dermal absorption.  Also the more limited volatility of flumioxazin in the 
outdoor environment should also not result in any appreciable concentrations in outdoor air. 
 
Table 9. Risk Assessment Parameters and Risk Quotients for Muskrats and Beavers 
Species Peak 
concentration, 
mg/L* 
Acute 
RfD, 
mg/kg 
Acute 
RQ 
21-d avg. conc. 
mg/L 
Chronic 
RfD, 
mg/kg 
Chronic 
RQ 
Muskrat 0.2 0.572 0.03 0.0749 0.381 0.02 
beaver 0.2 0.297 0.05 0.0749 0.198 0.03 
           * assumed maximum initial concentration as applied. 
 
 
References: 
 
Backhaus, T. and M. Faust. 2012. Predictive environmental risk assessment of chemical 
mixtures: a conceptual framework. Environ. Sci. Technol. 46:2564-2573.  
Charles River Laboratories. n.d. Weight versus age and price list for Sprague Dawley rats. 
http://www.criver.com/SiteCollectionDocuments/rm_rm_c_sprague_dawley_rats.pdf. 
Accessed 6/4/2013. 
Junghans, M., T. Backhaus, M. Faust, M. Scholze, and L.H. Grimme. 2006. Application and 
validation of approaches for predictive hazard assessment of realistic pesticide mixtures. 
Aquatic Toxicology 76: 93-110. 
Lydy, M., J. Belden, C. Wheelock, B. Hammock, and D. Denton. 2004. Challenges in regulating 
pesticide mixtures. Ecology and Society 9:1-15. 
USEPA. 1993. Wildlife Exposure Factors Handbook, 2 vol. EPA/600/R-93/187. Washington, 
DC, US Environmental Protection Agency, Office of Research and Development. 
USEPA. 1999. Data Collection For The Hazardous Waste Identification Rule Section 12.0 
Ecological Exposure Factors. Washington, DC, US Environmental Protection Agency. 
Office of Solid Waste: 48 pp. 
USEPA. 2011a.  Flumioxazin: Human Health Risk Scoping Document in Support of Registration 
Review. Memorandum by: D. Dotson et al., Health Effects Division, Office of Pesticide Program. 
Available at: regulations.gov, docket ID: EPA-HQ-OPP-2011-0176 
(http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-0176-0003)  
USEPA. 2011b. Recommended Use of Body Weight 3/4 as the Default Method in Derivation of 
the Oral Reference Dose. EPA/100/R11/0001. Final. Washington, DC, US Environmental 
Protection Agency. Office of the Science Advisor. Risk Assessment Forum. 
 
 
